<?xml version="1.0" encoding="UTF-8"?>
<Gazette>
<Record>
<MetaId><![CDATA[30555]]></MetaId>
<Doc_Style_LName><![CDATA[法規]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[中央法規標準法第3條之7種命令]]></Doc_Style_SName>
<Chapter><![CDATA[外交、國防及法務篇]]></Chapter>
<PubGov><![CDATA[國防部]]></PubGov>
<PubGovName><![CDATA[國防部]]></PubGovName>
<UndertakeGov><![CDATA[國防部]]></UndertakeGov>
<Officer_name><![CDATA[部長 陳肇敏]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[國制研審字第0980000164號]]></GazetteId>
<Title><![CDATA[國防部令：修正「常備兵補充兵服役規則」第33條條文]]></Title>
<TitleEnglish><![CDATA[MINISTRY OF NATIONAL DEFENSE Order is hereby given, for the amendment on Article 33 of "Service Regulations for Standing Armed Soldiers and Replacement Servicemen"]]></TitleEnglish>
<ThemeSubject><![CDATA[修正「常備兵補充兵服役規則」第三十三條條文。]]></ThemeSubject>
<Keyword><![CDATA[常備兵補充兵服役規則;常備兵;役期;國家體育競技代表隊;補充兵役(補充役);證明書(證明文件);軍事訓練]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[修正「常備兵補充兵服役規則」第三十三條條文。
    附修正「常備兵補充兵服役規則」第三十三條條文。]]></Explain>
<Category><![CDATA[240]]></Category>
<Cake><![CDATA[J32;312;181]]></Cake>
<Service><![CDATA[4Z0]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch03/type1/gov21/num1/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:15%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.mnd.gov.tw/">國防部</a>令</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">國制研審字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980000164</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="0131-1" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">修正「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1F0040011">常備兵補充兵服役規則</a>」第三十三條條文。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0132-2" style="margin-left:33.15pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">附修正「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1F0040011">常備兵補充兵服役規則</a>」第三十三條條文</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">部　　長　陳肇敏</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span lang="EN-US"><o:p>
                            &nbsp; 
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span lang="EN-US">
                            </o:p>
                            </span></font></p>
                            <p class="021"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman"><b>常備兵補充兵服役規則第三十三條修正條文</b></span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">第三十三條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;   
                            </span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">補充兵役人員依常備兵現役補缺規定，徵集或召集遞補常備兵者，即轉服常備兵役。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">補充兵應召服現役期間，適用常備兵服役規定。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">役齡男子因家庭因素或選入國家體育競技代表隊，經核定服補充兵役者，自核定之日起，五年內核定原因消滅，原核定機關應函送國防部以常備兵現役補缺，辦理臨時召集，依法補服常備兵現役不足之役期。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">前項補滿常備兵現役，連同補充兵證明書所載實際軍事訓練及應召服現役期間，合計一年。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30569]]></MetaId>
<Doc_Style_LName><![CDATA[法規]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[中央法規標準法第3條之7種命令]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[財政部]]></PubGov>
<PubGovName><![CDATA[財政部]]></PubGovName>
<UndertakeGov><![CDATA[財政部賦稅署]]></UndertakeGov>
<Officer_name><![CDATA[部長 李述德]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[台財稅字第09804519040號]]></GazetteId>
<Title><![CDATA[財政部令：修正「股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法」]]></Title>
<TitleEnglish><![CDATA[MINISTRY OF FINANCE Order is hereby given, for the amendment of "Regulations Governing the Application of Investment Tax Credits to Urban Renewal Entities in the Form of a Company Limited by Shares Participating in the Renewal Projects of Urban Areas"]]></TitleEnglish>
<ThemeSubject><![CDATA[修正「股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法」。]]></ThemeSubject>
<Keyword><![CDATA[股份有限公司;投資抵減;都市更新事業;都市更新;證明書(證明文件);變更登記;稽徵機關;營利事業所得稅(營所稅);抵減稅額(抵稅);費用(收費)]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[修正「股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法」。
    附修正「股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法」]]></Explain>
<Category><![CDATA[510]]></Category>
<Cake><![CDATA[J32;454;862]]></Cake>
<Service><![CDATA[641]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type1/gov30/num2/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:15%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.mof.gov.tw/mp.asp?mp=1">財政部</a>令</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">台財稅字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09804519040</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="0131-1" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">修正「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0040041">股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法</a>」。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0132-2" style="margin-left:33.15pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">附修正「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0040041">股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法</a>」</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">部　　長　李述德</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm">　</p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="021" style="margin-top:1.0gd;margin-right:0cm;margin-bottom:.5gd;
margin-left:0cm;line-height:normal"><font size="2"><b><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;letter-spacing:-.05pt">股份有限公司組織之都市更新事業機構投資於都市更新地區適用投資抵減辦法修正</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條文</span></b></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　一　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本辦法依都市更新條例（以下簡稱本條例）第四十九條第三項規定訂定之。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　二　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本條例第四十九條第一項所稱股份有限公司組織之都市更新事業機構（以下簡稱都市更新事業機構），指依公司法設立且依本條例規定，在更新地區內實施重建、整建或維護事業之股份有限公司。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本條例第四十九條第一項所稱經主管機關劃定應實施都市更新地區，指依本條例第五條、第六條及第七條規定劃定，並依同條例第八條規定程序辦理公告實施之都市更新地區。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本條例第四十九條第一項所稱投資總額，指按其經主管機關核定之都市更新事業計畫實際發生於規劃設計階段，實施都市更新事業規劃設計業務，且未依其他法令規定申請適用投資抵減之下列規劃、設計費用：</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">擬定都市更新計畫概要計畫書、都市更新事業計畫書及權利變換計畫書之製作費用。</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、政府規費。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、不動產估價費。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">四、建築設計費。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">五、更新作業之其他專業技師報告費及簽證費。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">六、其他為都市更新整合召開說明會、協調會及公聽會費用。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項所稱規劃設計階段，指自開始規劃都市更新事業計畫至本條例第十九條第一項規定經各級政府主管機關審議通過之日止。但嗣後變更都市更新計畫經各級政府主管機關審議通過者，其變更計畫所支付之規劃、設計費用，亦得適用。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前二項適用投資抵減之規劃、設計費用，不包括政府補助款在內，且應以稅捐稽徵機關核定數為準。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本條例第四十九條第一項所稱抵減其都市更新事業計畫完成年度應納營利事業所得稅額，指扣抵其都市更新事業計畫經主管機關核定實際完成年度依管轄稽徵機關核定當年度之營利事業所得額依規定稅率計算之應納稅額。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　三　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">都市更新事業機構依本辦法規定申請適用投資抵減者，其都市更新事業計畫除應敘明本條例第二十一條規定之事項外，另應敘明下列事項：</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、公司名稱、所在地、及代表人姓名、住所。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、預定從事前條第三項及第四項規定之費用項目、金額及支出時間。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、預定開工日期、施工進度表及預定完成日期。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">主管機關於核發前項核定函時，應副知管轄稽徵機關，都市更新事業計畫展延或變更時亦同。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　四　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">都市更新事業機構應自核定之都市更新事業計畫完成之日起六個月內，檢附其實際支付第二條第三項及第四項規定費用之相關證明文件向原核定主管機關申請核發投資抵減證明。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項都市更新事業計畫完成之日，以經主管機關核定者為準。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">第一項投資抵減證明之格式由中央主管機關定之。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">主管機關於核發第一項投資抵減證明時，應副知管轄稽徵機關。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　五　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">都市更新事業機構依本條例第四十九條第一項規定申請抵減應納營利事業所得稅額者，按其實際投資總額依下列百分比範圍內，抵減其都市更新事業計畫完成年度應納營利事業所得稅額，當年度不足抵減時，得在以後四年內抵減之。</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">都市更新事業計畫於主管機關核定之預定完成期限內完成者，抵減百分之二十。</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">二、 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">都市更新事業計畫於主管機關核定之預定完成期限之日起五年內完成者，抵減百分之十。</span></span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">三、 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">都市更</span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新事業計畫於主管機關核定之預定完成期限之日起逾五年以上始完成者，抵減百分之五。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項投資抵減，其每一年度得抵減總額，以不超過該機構當年度應納營利事業所得稅額百分之五十為限。但最後年度抵減金額，不在此限。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">都市更新事業機構依第一項規定辦理該年度營利事業所得稅結算申報時，應檢附投資抵減證明及公司執照影本，向管轄稽徵機關申請抵減營利事業所得稅。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　六　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">都市更新事業機構有下列情形之一者，主管機關應不予核發或撤銷原核發之投資抵減證明。</span></font></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">一、都市更新事業計畫或其證明文件有虛偽不實者。</font></span></p>
                            <p class="032" style="text-indent: -22.1pt; margin-left: 96pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、未依核定之都市更新事業計畫執行者。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">依前項規定撤銷原核定之投資抵減證明者，主管機關並應通知管轄稽徵機關依稅捐稽徵法及所得稅法之規定辦理。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　七　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp; 
                            &nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本辦法自發布日施行。</span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30556]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[公示送達]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[財政部]]></PubGov>
<PubGovName><![CDATA[財政部臺灣省中區國稅局]]></PubGovName>
<UndertakeGov><![CDATA[財政部臺灣省中區國稅局]]></UndertakeGov>
<Officer_name><![CDATA[局長 趙榮芳]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[中區國稅沙鹿三字第0980004329號]]></GazetteId>
<Title><![CDATA[財政部臺灣省中區國稅局對納稅義務人吉兒家文教事業股份有限公司營業稅調閱帳證文據通知函公示送達]]></Title>
<TitleEnglish><![CDATA[NATIONAL TAX ADMINISTRATION OF CENTRAL TAIWAN PROVINCE, MOF Notice served as public announcement, for prescribing to request reviewing  attestation-related documents and audit working papers pertaining to Business Tax paid by 吉兒家文教事業股份有限公司(the English name of this enterprise is not given or found)]]></TitleEnglish>
<ThemeSubject><![CDATA[公示送達納稅義務人吉兒家文教事業股份有限公司營業稅調閱帳證文據通知函。]]></ThemeSubject>
<Keyword><![CDATA[納稅義務人(納稅人);營業稅;名冊;營利事業]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[公示送達名冊所列旨揭營利事業應為送達之處所不明，致主旨所述文書無法送達，依法辦理公示送達，並自最後刊登之日起，經20日發生送達效力，請納稅義務人速攜帶公司行號及負責人印章至財政部臺灣省中區國稅局沙鹿稽徵所洽領主旨所示文書，逾期未領，即依有關規定處理，請勿延誤，特此公告。]]></Explain>
<Category><![CDATA[510]]></Category>
<Cake><![CDATA[452]]></Cake>
<Service><![CDATA[641]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type3/gov30/num6/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:30%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><a href="http://www.ntact.gov.tw/frontend/main/main.asp"><b>財政部臺灣省中區國稅局</b></a><b>公告</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">中區國稅沙鹿三字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980004329</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">主　　旨：公示送達納稅義務人吉兒家文教事業股份有限公司營業稅調閱帳證文據通知函。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第</span><span lang="EN-US">78</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條、第</span><span lang="EN-US">80</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">條及第</span><span lang="EN-US">81</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">條。</span></font></p>
                            <p class="011" style="text-indent: -49pt; margin-left: 49pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">公告事項：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">公示送達名冊所列旨揭營利事業應為送達之處所不明，致主旨所述文書無法送達，依法辦理公示送達，並自最後刊登之日起，經</span><span lang="EN-US">20</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">日發生送達效力，請納稅義務人速攜帶公司行號及負責人印章至財政部臺灣省中區國稅局沙鹿稽徵所洽領主旨所示文書，逾期未領，即依有關規定處理，請勿延誤，特此公告。</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt"><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">局　　長　趙榮芳</font></span><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman"><br>
                            </span>　　　　　<span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">依分層負責授權由單位主管決行並鈐印（</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">9</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">）</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="021">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>財政部臺灣省中區國稅局營業稅公示送達名冊</b></font></span></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt"><img border="0" src="images/images001.gif"></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">附註：依據行政程序法第</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">78</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條、第</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">80</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條及第</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">81</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條規定辦理。</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30564]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規命令訂定、修正草案及廢止案之預告]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[經濟部]]></PubGov>
<PubGovName><![CDATA[經濟部]]></PubGovName>
<UndertakeGov><![CDATA[經濟部工業局]]></UndertakeGov>
<Officer_name><![CDATA[部長 尹啟銘]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[經授工字第09820403481號]]></GazetteId>
<Title><![CDATA[經濟部公告：預告「電腦軟體分級辦法」修正草案]]></Title>
<TitleEnglish><![CDATA[MINISTRY OF ECONOMIC AFFAIRS Notice is hereby given, to commenced a period of public comment for the draft amendment of "Regulations on Computer Software Rating System"]]></TitleEnglish>
<ThemeSubject><![CDATA[預告修正「電腦軟體分級辦法」草案，名稱並修正為「電腦及遊戲軟體分級辦法」。]]></ThemeSubject>
<Keyword><![CDATA[電腦軟體;遊戲軟體;電動玩具(電玩遊樂器，電動遊戲，遊戲機);電子遊戲機;分級制度]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、修正機關：經濟部。
二、修正依據：兒童及少年福利法第二十七條第三項。
三、電腦軟體分級辦法修正草案如附件。本案另載於本部工業局全球資訊網站（網址：http:// www.moeaidb.gov.tw），「法令規章」網頁。
四、對公告內容有任何意見或修正建議者，請於本公告刊登公報之日起7日內陳述意見或洽詢：
（一）承辦單位：經濟部工業局
（二）地址：台北市信義路三段41之3號
（三）電話：02-27541255-2205
（四）傳真：02-27048128
（五）電子郵件：sychyi@moeaidb.gov.tw]]></Explain>
<Category><![CDATA[550]]></Category>
<Cake><![CDATA[J33;713]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type3/gov31/num3/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width: 775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格" height="891">
					<tr>
						<td style="width: 15%" height="13">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.moea.gov.tw/">經濟部</a>公告</b></font></span>
						</td>
						<td style="width: 601 px" height="13">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">經授工字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09820403481</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width: 733px" height="828">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">主　　旨：預告修正「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030086">電腦軟體分級辦法</a>」草案，名稱並修正為「電腦及遊戲軟體分級辦法」。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第一百五十一條第二項準用第一百五十四條第一項。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">公告事項：</font></span></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、修正機關：經濟部。</font></span></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、修正依據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1D0050001">兒童及少年福利法</a>第二十七條第三項。</font></span></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030086">電腦軟體分級辦法</a>修正草案如附件。本案另載於本部工業局全球資訊網站（網址：</span><a href="http://www.moeaidb.gov.tw"><span lang="EN-US">http://www.moeaidb.gov.tw</span></a><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">），「法令規章」網頁。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、對公告內容有任何意見或修正建議者，請於本公告刊登公報之日起</span><span lang="EN-US">7</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">日內陳述意見或洽詢：</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;  
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">承辦單位：經濟部工業局</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;  
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">地址：台北市信義路三段</span><span lang="EN-US">41</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">之</span><span lang="EN-US">3</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">號</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;  
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電話：</span><span lang="EN-US">02-27541255-2205</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;  
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">傳真：</span><span lang="EN-US">02-27048128</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;  
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電子郵件：</span><span lang="EN-US"><a href="mailto:sychyi@moeaidb.gov.tw">sychyi@moeaidb.gov.tw</a></span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">部　　長　尹&#21843;銘</font></span></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm">　</p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>電腦軟體分級辦法修正草案總說明</b></font></span></p>
                            <p class="014" style="text-indent:22.0pt"><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">電腦軟體分級辦法自九十五年七月六日公布以來，迄今已近三年，由於科技發展之日新月異，遊戲種類與內容不斷更迭，現行規定已無法符合實際需求，有進行全面檢討之必要。</font></span></p>
                            <p class="014" style="text-indent:22.0pt"><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">鑒於電腦軟體分級辦法之名稱，無法將電腦以外平台之數位遊戲機（含電視遊樂器、掌上型電玩）納入規範，外界易有分級規範不周延之批評，乃將名稱修正為「電腦及遊戲軟體分級辦法」，另配合增訂數位遊戲機之分級規範，酌修電腦及遊戲軟體之定義，並將已有專法規範之大型電子遊戲機台排除於外，以充分保護兒童及少年之身心健康，爰擬具「電腦軟體分級辦法」修正草案，其修正要點如下：</font></span></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正電腦及遊戲軟體之定義，將數位遊戲機之平台（含電視遊樂器、掌上型電玩）納入，並將大型電子遊戲機台予以排除。（修正條文第二條）</span></font></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、配合法規名稱修正爰作文字調整。（修正條文第三條至第十條）</font></span></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">為使業者有充分準備之緩衝期，遊戲軟體分級之規定，爰訂於九十八年十月八日施行。（修正條文第十一條）</span></font></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt;line-height:13.5pt;
mso-line-height-rule:exactly"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p> 
                            </font></span></p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>電腦軟體分級辦法修正草案條文對照表</b></font></span></p>
                            <table border="1" cellspacing="0" cellpadding="0" width="609" style="width:457.05pt;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0cm 1.4pt 0cm 1.4pt">
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:2.4pt;margin-bottom:.0001pt;text-align:center"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">修　正　名　稱</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border:solid windowtext .5pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="045-2" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:2.4pt;margin-bottom:.0001pt;text-align:center"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">現　行　名　稱</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border:solid windowtext .5pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="045-2" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:2.4pt;margin-bottom:.0001pt;text-align:center"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">說　　　　　明</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體分級辦法</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">電腦軟體分級辦法</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">為將數位遊戲機（含電視遊樂器、掌上型電玩）納入分級規範，爰修正法規名稱。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:13.4pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">修　正　條　文</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:13.4pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">現　行　條　文</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:13.4pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">說　　　　　明</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第一條　本辦法依兒童及少年福利法第二十七條第三項規定訂定之。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第一條　本辦法依兒童及少年福利法第二十七條第三項規定訂定之。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本條未修正。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第二條　本辦法用詞定義如下：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體：指<u>除大型電子遊戲機台外，安裝於電腦、數位遊戲機之平台（含電視遊樂器、掌上型電玩）</u>使用之電腦<u>及遊戲</u>軟體。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體提供者：指電腦<u>及遊戲</u>軟體之發行、租售、散布、展示陳列或提供下載者。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第二條　本辦法用詞定義如下：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦軟體：指安裝於電腦使用之遊戲軟體，未包括電腦外之其他平台。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦軟體提供者：指電腦軟體之發行、租售、散布、展示陳列或提供下載者。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="044-1" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:24.5pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">新增遊戲軟體之定義為：數位遊戲機（含電視遊樂器、掌上型電玩）之平台所使用之遊戲軟體，惟有關大型電子遊戲機台係由經濟部商業司以專法主管，故將其排除於外。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:24.5pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第三條　電腦<u>及遊戲</u>軟體內容不得違反法律強制或禁止規定。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第三條　電腦軟體內容不得違反法律強制或禁止規定。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第四條　電腦<u>及遊戲</u>軟體提供者應將電腦<u>及遊戲</u>軟體分為下列四級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">限制級：未滿十八歲者不得使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">輔導級：未滿十二歲之兒童不得使用，十二歲以上未滿十八歲之少年需父母或師長輔導使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">保護級：未滿六歲之兒童不得使用，六歲以上未滿十二歲之兒童需由父母、師長或成年親友陪伴使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">普遍級：一般軟體使用者皆可使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第四條　電腦軟體提供者應將電腦軟體分為下列四級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">限制級：未滿十八歲者不得使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">輔導級：未滿十二歲之兒童不得使用，十二歲以上未滿十八歲之少年需父母或師長輔導使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">保護級：未滿六歲之兒童不得使用，六歲以上未滿十二歲之兒童需由父母、師長或成年親友陪伴使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">普遍級：一般軟體使用者皆可使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第五條　電腦<u>及遊戲</u>軟體之內容有下列情形之一者，列為限制級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">除輔導級內容外，無渲染色情與猥褻之全裸畫面。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">以動作、影像、語言、文字、對白、聲音表現淫穢情態或強烈性暗示，尚不致引起一般成年人羞恥感或厭惡感。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">涉及人被殺害並產生血腥之畫面，及其他表現方式強烈之恐怖、血腥、殘暴或變態之情節。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">描述其他犯罪行為而對未滿十八歲者之行為、心理有不良影響之虞。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第五條　電腦軟體之內容有下列情形之一者，列為限制級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">除輔導級內容外，無渲染色情與猥褻之全裸畫面。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">以動作、影像、語言、文字、對白、聲音表現淫穢情態或強烈性暗示，尚不致引起一般成年人羞恥感或厭惡感。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">涉及人被殺害並產生血腥之畫面，及其他表現方式強烈之恐怖、血腥、殘暴或變態之情節。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">描述其他犯罪行為而對未滿十八歲者之行為、心理有不良影響之虞。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第六條　電腦<u>及遊戲</u>軟體之內容有下列情形之一者，列為輔導級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">真實、虛擬或可愛卡通人物被殺害並產生血腥。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">裸露上半身、背面全裸、遠處全裸、透過毛玻璃或其他部分或處理過之裸露。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">犯罪、恐怖、玄奇怪異、反映社會畸形現象、褻瀆、粗鄙字眼、對白有不良隱喻及其他對兒童與少年心理有不良影響。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第六條　電腦軟體之內容有下列情形之一者，列為輔導級：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">真實、虛擬或可愛卡通人物被殺害並產生血腥。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">裸露上半身、背面全裸、遠處全裸、透過毛玻璃或其他部分或處理過之裸露。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">犯罪、恐怖、玄奇怪異、反映社會畸形現象、褻瀆、粗鄙字眼、對白有不良隱喻及其他對兒童與少年心理有不良影響。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第七條　電腦<u>及遊戲</u>軟體之內容涉及描述兩性不同性特徵、可愛卡通人物裸露上半身、被殺害或被消滅之畫面、一般溫和之咒罵語及其他有混淆道德秩序觀念之虞內容，列為保護級。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第七條　電腦軟體之內容涉及描述兩性不同性特徵、可愛卡通人物裸露上半身、被殺害或被消滅之畫面、一般溫和之咒罵語及其他有混淆道德秩序觀念之虞內容，列為保護級。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第八條　電腦<u>及遊戲</u>軟體中無任何暴露、暴力、血腥、恐怖、變態、毒品、犯罪、不雅言語及前三條描述之內容者，列為普遍級。可愛卡通人物打鬥畫面，列為普遍級。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第八條　電腦軟體中無任何暴露、暴力、血腥、恐怖、變態、毒品、犯罪、不雅言語及前三條描述之內容者，列為普遍級。可愛卡通人物打鬥畫面，列為普遍級。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第九條　電腦<u>及遊戲</u>軟體提供者應依規定，於電腦<u>及遊戲</u>軟體發行、租售、散布、展示陳列、供應或提供下載前，自行分級；對於自行分級有疑義者，得諮詢經濟部工業局之意見。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="043-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.8pt;margin-bottom:.0001pt;text-indent:22.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">前項以外之任何人，對於電腦<u>及遊戲</u>軟體提供者之分級有異議時，得諮詢經濟部工業局之意見。</span><u><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></u></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第九條　電腦軟體提供者應依規定，於電腦軟體發行、租售、散布、展示陳列、供應或提供下載前，自行分級；對於自行分級有疑義者，得諮詢經濟部工業局之意見。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="043-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.8pt;margin-bottom:.0001pt;text-indent:22.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">前項以外之任何人，對於電腦軟體提供者之分級有異議時，得諮詢經濟部工業局之意見。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第十條　電腦<u>及遊戲</u>軟體提供者應依下列規定標示：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體應於產品包裝或提供下載之網頁，為明顯之分級標示，限制級電腦<u>及遊戲</u>軟體並應註明滿十八歲之人始得購買或使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體產品包裝或提供下載之網頁應與該軟體之分級等級相符，且不得有限制級之內容。但電腦<u>及遊戲</u>軟體提供者，如採取合理措施防止未滿十八歲之未成年人接觸限制級產品包裝或提供下載之網頁，不在此限。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦<u>及遊戲</u>軟體提供者除依第一款規定標示外，並應依商品標示相關規定標示內容型態、遊戲使用時間警語及其他應行標示事項。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第十條　電腦軟體提供者應依下列規定標示：</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">一、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦軟體應於產品包裝或提供下載之網頁，為明顯之分級標示，限制級電腦軟體並應註明滿十八歲之人始得購買或使用。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">二、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦軟體產品包裝或提供下載之網頁應與該軟體之分級等級相符，且不得有限制級之內容。但電腦軟體提供者，如採取合理措施防止未滿十八歲之未成年人接觸限制級產品包裝或提供下載之網頁，不在此限。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="042-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:35.9pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">三、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                                  </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">電腦軟體提供者除依第一款規定標示外，並應依商品標示相關規定標示內容型態、遊戲使用時間警語及其他應行標示事項。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">配合法規名稱修正爰予文字調整。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="214" valign="top" style="width:160.6pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第十一條　本辦法自中華民國九十八年十月八日施行。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="214" valign="top" style="width:160.65pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="041-" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:13.4pt;margin-bottom:.0001pt;text-indent:-11.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">第十一條　本辦法自發布後六個月施行。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="181" valign="top" style="width:135.8pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="045-2" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:2.4pt;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">有關遊戲軟體分級規定，為使業者有充分準備之緩衝期，爰自九十八年十月八日施行。</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                            </table>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30565]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[權限委任、委託之公告]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[經濟部]]></PubGov>
<PubGovName><![CDATA[經濟部]]></PubGovName>
<UndertakeGov><![CDATA[經濟部工業局]]></UndertakeGov>
<Officer_name><![CDATA[部長 尹啟銘]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[經授工字第09820404060號]]></GazetteId>
<Title><![CDATA[經濟部公告：委託財團法人資訊工業策進會成立「經濟部工業局研貸專案辦公室」，並協助推動「促進產業研究發展貸款計畫」，自98年3月30日生效]]></Title>
<TitleEnglish><![CDATA[MINISTRY OF ECONOMIC AFFAIRS Notice is hereby given, for Institute for Information Industry to be commissioned to establish the Project Office for Industry R&D Loan Schemes (period of commission has commenced since 30th, March 2009)]]></TitleEnglish>
<ThemeSubject><![CDATA[公告本部自中華民國98年3 月30日起，委託財團法人資訊工業策進會執行「促進產業研究發展貸款計畫」，並成立「經濟部工業局研貸專案辦公室」協助本部推動「促進產業研究發展貸款計畫」。]]></ThemeSubject>
<Keyword><![CDATA[委託辦理(委辦);資訊工業策進會(資策會);產業研發;經濟部工業局;貸放款(融資融通，貸款);國家發展基金(國發基金);推廣;審查;撥款;簽約]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[本部委託財團法人資訊工業策進會成立「經濟部工業局研貸專案辦公室」，協助本部推動「促進產業研究發展貸款計畫」，委託範圍如下：
一、辦理「促進產業研究發展貸款辦法」與行政院國家發展基金管理會、經理銀行間三方協議書之修訂。
二、管理「促進產業研究發展貸款辦法」經理銀行與承貸銀行間之簽約、撥款或收款、追償、貸放執行績效報告等相關事項。
三、辦理「促進產業研究發展貸款計畫」之推廣與諮詢。
四、受理企業申請「促進產業研究發展貸款計畫」暨各項審查。
五、具函通知申請廠商審查結果。
六、辦理「促進產業研究發展貸款辦法」廠商各期貸款款項之撥付。
七、辦理「促進產業研究發展貸款計畫」管理事項：含工作報告、全程總結報告之繳交、查證及結案、計畫變更(延長)及其他計畫管理作業手冊所含各項作業等事項。
八、具函通知執行廠商結案報告審查結果。]]></Explain>
<Category><![CDATA[550]]></Category>
<Cake><![CDATA[7Y1;7A1;7A3]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type3/gov31/num4/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:15%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.moea.gov.tw/">經濟部</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">經授工字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09820404060</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="text-indent: -50pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">主　　旨：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">公告本部自中華民國</span><span lang="EN-US">98</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">年</span><span lang="EN-US">3</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">月</span><span lang="EN-US">30</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">日起，委託財團法人資訊工業策進會執行「促進產業研究發展貸款計畫」，並成立「經濟部工業局研貸專案辦公室」協助本部推動「促進產業研究發展貸款計畫」。</span></font></p>
                            <p class="011" style="text-indent: -50pt; margin-left: 50pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依　　據：</font></span></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030074">促進產業研究發展貸款辦法</a>第</span><span lang="EN-US">4</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條第</span><span lang="EN-US">3</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">項。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第</span><span lang="EN-US">16</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條第</span><span lang="EN-US">1</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">項、第</span><span lang="EN-US">2</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">項。</span></font></p>
                            <p class="011" style="text-indent: -50pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">公告事項：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本部委託財團法人資訊工業策進會成立「經濟部工業局研貸專案辦公室」，協助本部推動「促進產業研究發展貸款計畫」，委託範圍如下：</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、辦理「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030074">促進產業研究發展貸款辦法</a>」與行政院國家發展基金管理會、經理銀行間三方協議書之修訂。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、管理「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030074">促進產業研究發展貸款辦法</a>」經理銀行與承貸銀行間之簽約、撥款或收款、追償、貸放執行績效報告等相關事項。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、辦理「促進產業研究發展貸款計畫」之推廣與諮詢。</font></span></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、受理企業申請「促進產業研究發展貸款計畫」暨各項審查。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五、具函通知申請廠商審查結果。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">六、辦理「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030074">促進產業研究發展貸款辦法</a>」廠商各期貸款款項之撥付。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">七、辦理「促進產業研究發展貸款計畫」管理事項：含工作報告、全程總結報告之繳交、查證及結案、計畫變更（延長）及其他計畫管理作業手冊所含各項作業等事項。</span></font></p>
                            <p class="0121" style="text-indent: -20pt; margin-left: 50pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">八、具函通知執行廠商結案報告審查結果。</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">部　　長　尹&#21843;銘</font></span></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30563]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[依法規應公告之事項]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[經濟部]]></PubGov>
<PubGovName><![CDATA[經濟部工業局]]></PubGovName>
<UndertakeGov><![CDATA[經濟部工業局]]></UndertakeGov>
<Officer_name><![CDATA[局長 杜紫軍]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[工知字第09800262273號]]></GazetteId>
<Title><![CDATA[經濟部工業局公告：公告「工業局產學聯合研發計畫之補助資格條件及補助比率限制」]]></Title>
<TitleEnglish><![CDATA[INDUSTRIAL DEVELOPMENT BUREAU, MOEA Notice is hereby given, for the stipulation of "Subsidize Limitation, Ratio and Qualification Granted to Industry and Universities/Colleges Collaboration in Innovation Research"]]></TitleEnglish>
<ThemeSubject><![CDATA[公告「工業局產學聯合研發計畫之補助資格條件及補助比率限制」。]]></ThemeSubject>
<Keyword><![CDATA[建教合作(產學合作);經費補助;政府補助;大專校院(大專院校);產業研發]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、補助資格條件：由教育部核准設立之公私立大專院校以合作方式邀請企業參與提案。
二、補助比率限制：不得超過申請補助計畫全案總經費百分之九十。]]></Explain>
<Category><![CDATA[550]]></Category>
<Cake><![CDATA[E57;715]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type3/gov31/num5/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><b><a href="http://www.moeaidb.gov.tw/">經濟部工業局</a>公告</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line"><br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">工知字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09800262273</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">主　　旨：公告「工業局產學聯合研發計畫之補助資格條件及補助比率限制」。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">依　　據：<a href="http://law.moj.gov.tw/Scripts/NewsDetail.asp?no=1J0030088&amp;KeyWordID=4311&amp;KCDate=2009-4-2&amp;FL=">經濟部工業局協助產業發展補助辦法</a>第</span><span lang="EN-US">7</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條、第</span><span lang="EN-US">8</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">條規定。</span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">公告事項：</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、補助資格條件：由教育部核准設立之公私立大專院校以合作方式邀請企業參與提案。</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、補助比率限制：不得超過申請補助計畫全案總經費百分之九十。</font></span></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2">局　　長　杜紫軍</font></span></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30566]]></MetaId>
<Doc_Style_LName><![CDATA[其他]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[更正]]></Doc_Style_SName>
<Chapter><![CDATA[財政經濟篇]]></Chapter>
<PubGov><![CDATA[金管會]]></PubGov>
<PubGovName><![CDATA[金融監督管理委員會]]></PubGovName>
<UndertakeGov><![CDATA[銀行局]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 陳?]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[金管銀(五)字第09850002680號]]></GazetteId>
<Title><![CDATA[行政院金融監督管理委員會書函：更正第015卷第050期本會98年3月13日金管銀(五)字第09800099141號公告之公告事項如勘誤表]]></Title>
<TitleEnglish><![CDATA[FINANCIAL SUPERVISORY COMMISSION, EXECUTIVE YUAN A correction of error in regarding to the previous publication from Vol. 015 No.050 of The Executive Yuan Gazette, which acknowledges the correction of the information of computer-processed personal data held and registered by CitiBank Taiwan]]></TitleEnglish>
<ThemeSubject><![CDATA[檢送美商花旗銀行「金融業電腦處理個人資料」變更登記事項公告勘誤表1份，請  查照更正。]]></ThemeSubject>
<Keyword><![CDATA[外商銀行(外國銀行);商業銀行;公司登記;變更登記;金融業(金融服務業);電腦處理個人資料保護法]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[美商花旗銀行「金融業電腦處理個人資料」變更登記事項業經本會中華民國98年3月13日金管銀(五)字第09800099141號公告發布在案。]]></Explain>
<Category><![CDATA[540]]></Category>
<Cake><![CDATA[472]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch04/type7/gov36/num7/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:30%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><a href="http://www.fscey.gov.tw/"><b>行政院金融監督管理委員會</b></a><b>書函</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">金管銀（五）字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09850002680</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">主　　旨：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;letter-spacing:-.05pt">檢送美商花旗銀行「金融業電腦處理個人資料」變更登記事項公告勘誤表</span><span lang="EN-US" style="letter-spacing:-.05pt">1</span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;
letter-spacing:-.05pt">份，請　查</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">照更正。</span></font></p>
                            <p class="011" style="text-indent: -49pt; margin-left: 49pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">說　　明：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">美商花旗銀行「金融業電腦處理個人資料」變更登記事項業經本會中華民國</span><span lang="EN-US">98</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">年</span><span lang="EN-US">3</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">月</span><span lang="EN-US">13</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">日金管銀（五）字第</span><span lang="EN-US">09800099141</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">號公告發布在案。</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt"><font size="2"><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">行政院金融監督管理委員會<br>
                            </span><span style="mso-bidi-font-size: 12.0pt" lang="EN-US">　　　　　</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">授權單位主管決行並鈐印</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="021">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>美商花旗銀行金融業電腦處理個人資料變更登記事項公告事項勘誤表</b></font></span></p>
                            <table border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;
 border:none;mso-border-alt:solid windowtext .5pt;mso-padding-alt:0cm 1.4pt 0cm 1.4pt">
                              <tr style="height:5.65pt">
                                <td width="304" style="width:227.8pt;border:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="045-2" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:2.4pt;margin-bottom:.0001pt;text-align:center"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;"><font size="2">更正後文字</font></span></p>
                                </td>
                                <td width="304" style="width:227.85pt;border:solid windowtext .5pt;border-left:
  none;mso-border-left-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="045-2" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:2.4pt;margin-bottom:.0001pt;text-align:center"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;"><font size="2">原列文字</font></span></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="304" valign="top" style="width:227.8pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="011" style="text-indent: -50pt; margin-left: 50pt; margin-right: .2gd"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">公告事項：</span><span style="mso-tab-count:
  1" lang="EN-US"> </span><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">原國際傳遞個人資料之直接收受者</span><span lang="EN-US">Citicorp  
                                  Global Services Limited</span><span style="font-family: 
  新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">更名為</span><span lang="EN-US">TCS  
                                  <u>eServe </u>Limited</span><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">。</span></font></p>
                                </td>
                                <td width="304" valign="top" style="width:227.85pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="011" style="text-indent: -50pt; margin-left: 50pt; margin-right: .2gd"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">公告事項：</span><span style="mso-tab-count:
  1" lang="EN-US"> </span><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">原國際傳遞個人資料之直接收受者</span><span lang="EN-US">Citicorp  
                                  Global Services Limited</span><span style="font-family: 
  新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">更名為</span><span lang="EN-US">TCS  
                                  eServices Limited</span><span style="font-family:新細明體; 
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">。</span></font></p>
                                </td>
                              </tr>
                            </table>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30559]]></MetaId>
<Doc_Style_LName><![CDATA[處分]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規規定應刊登之處分]]></Doc_Style_SName>
<Chapter><![CDATA[交通建設篇]]></Chapter>
<PubGov><![CDATA[工程會]]></PubGov>
<PubGovName><![CDATA[公共工程委員會]]></PubGovName>
<UndertakeGov><![CDATA[公共工程委員會]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 范良銹]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月27日]]></Date_Created>
<GazetteId><![CDATA[工程技字第09800109921號]]></GazetteId>
<Title><![CDATA[行政院公共工程委員會公告：核准喬聯工程顧問股份有限公司申請換發工程技術顧問公司登記證，並變更登記事項之營業範圍之科別]]></Title>
<TitleEnglish><![CDATA[PUBLIC CONSTRUCTION COMMISSION, EXECUTIVE YUAN Approval granted for re-certification of the engineering consultant certificate held by 喬聯工程顧問股份有限公司(the full name of this engineering consultant Incorporation in English is not given or found), and alteration of the license holding body's information by changing the type of engineering described in the scope of business]]></TitleEnglish>
<ThemeSubject><![CDATA[核准喬聯工程顧問股份有限公司申請換發工程技術顧問公司登記證，並變更登記事項之營業範圍之科別，特此公告。]]></ThemeSubject>
<Keyword><![CDATA[工程技術顧問公司;公司登記;變更登記;土木工程科]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、公司名稱：喬聯工程顧問股份有限公司
所 在 地：彰化縣員林鎮大同路2段124號
公司統一編號：97038283
二、董事長或代表人姓名：黃裕郎 
三、營業範圍：I101061工程技術顧問業（以土木工程科之工程技術事項為限）
四、工程技術顧問公司登記證字號：工程技顧登字第000174號]]></Explain>
<Category><![CDATA[660]]></Category>
<Cake><![CDATA[870]]></Cake>
<Service><![CDATA[623]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch06/type5/gov51/num8/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:30%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.pcc.gov.tw/">行政院公共工程委員會</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">27</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">工程技字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09800109921</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主　　旨：核准喬聯工程顧問股份有限公司申請換發工程技術顧問公司登記證，並變更登記事項之營業範圍之科別，特此公告。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">公告事項：</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">一、公司名稱：喬聯工程顧問股份有限公司</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="text-indent: -22.1pt; margin-left: 55.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">　　所</span> 
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">在</span>  
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">地：彰化縣員林鎮大同路2段124號<o:p> 
                            </o:p> 
                            </span></font></p>
                            <p class="0121" style="text-indent: -22.1pt; margin-left: 55.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">　　公司統一編號：97038283<o:p>
                            </o:p> 
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">二、董事長或代表人姓名：黃裕郎<o:p>
                            </o:p> 
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">三、營業範圍：I1010</span><span lang="EN-US">61</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">工程技術顧問業（以土木工程科之工程技術事項為限）</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">四、工程技術顧問公司登記證字號：工程技顧登字第</span><span lang="EN-US">000174</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">號</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主任委員　范良銹</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="text-indent: 49pt; mso-char-indent-count: 6.2; mso-char-indent-size: 9.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; margin-bottom: 6.0pt"><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">本案依分層負責規定授權業務主管決行</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30560]]></MetaId>
<Doc_Style_LName><![CDATA[處分]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規規定應刊登之處分]]></Doc_Style_SName>
<Chapter><![CDATA[交通建設篇]]></Chapter>
<PubGov><![CDATA[工程會]]></PubGov>
<PubGovName><![CDATA[公共工程委員會]]></PubGovName>
<UndertakeGov><![CDATA[公共工程委員會]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 范良銹]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月27日]]></Date_Created>
<GazetteId><![CDATA[工程技字第09800111361號]]></GazetteId>
<Title><![CDATA[行政院公共工程委員會公告：核准李大行換發技師執業執照，依技師法第6條第1項第2款方式執行土木工程科技師業務]]></Title>
<TitleEnglish><![CDATA[PUBLIC CONSTRUCTION COMMISSION, EXECUTIVE YUAN Approval granted for re-certification of the professional engineer license held by an engineer named as Li Ta-hsing in performing Civil Engineering in accordance with Subparagraph 2, Paragraph 1, Article 6 of "Professional Engineer Act"]]></TitleEnglish>
<ThemeSubject><![CDATA[核准李大行換發技師執業執照，依技師法第6條第1項第2款方式執行土木工程科技師業務，特此公告。]]></ThemeSubject>
<Keyword><![CDATA[技師;執業執照;土木工程科]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、技師姓名：李大行
二、執業方式：技師法第6條第1項第2款
三、執業機構名稱：亞新工程顧問股份有限公司
所   在   地：臺北市敦化南路1段3號11樓之1
四、技師科別證書字號：土木工程科  台工登字第7751號
五、業務範圍：如土木工程科執業範圍
六、執業執照字號：技執字第001238號
七、執照有效期間：自98年4月4日至102年4月3日止]]></Explain>
<Category><![CDATA[660]]></Category>
<Cake><![CDATA[872]]></Cake>
<Service><![CDATA[514]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch06/type5/gov51/num9/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:30%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.pcc.gov.tw/">行政院公共工程委員會</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span>年<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span>月<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">27</span>日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">工程技字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09800111361</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主　　旨：</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">核准李大行換發技師執業執照，依<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030022">技師法</a>第</span><span lang="EN-US">6</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條第</span><span lang="EN-US">1</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">項第</span><span lang="EN-US">2</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">款方式執行土木工程科技師業務，特此公告。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030022">技師法</a>第</span><span lang="EN-US">7</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">公告事項：</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">一、技師姓名：李大行</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">二、執業方式：技師法第6條第1項第2款<o:p>
                            </o:p>  
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">三、執業機構名稱：亞新工程顧問股份有限公司<o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="text-indent: -22.1pt; margin-left: 55.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">　　所&nbsp;&nbsp;   
                            在&nbsp;&nbsp; 地：臺北市敦化南路1段3號11樓之1<o:p>  
                            </o:p>  
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">四、技師科別證書字號：土木工程科　台工登字第7751號<o:p>
                            </o:p>  
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">五、業務範圍：如土木工程科執業範圍</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">六、執業執照字號：技執字第</span><span lang="EN-US">001238</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">號</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">七、執照有效期間：自</span><span lang="EN-US">98</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US">4</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US">4</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日至</span><span lang="EN-US">102</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US">4</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US">3</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日止</span><span lang="EN-US"><o:p>
                            </o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主任委員　范良銹</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="text-indent: 49pt; mso-char-indent-count: 6.2; mso-char-indent-size: 9.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; margin-bottom: 6.0pt"><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">本案依分層負責規定授權業務主管決行</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            <o:p>
                            </o:p> 
                            </span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30561]]></MetaId>
<Doc_Style_LName><![CDATA[處分]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規規定應刊登之處分]]></Doc_Style_SName>
<Chapter><![CDATA[交通建設篇]]></Chapter>
<PubGov><![CDATA[工程會]]></PubGov>
<PubGovName><![CDATA[公共工程委員會]]></PubGovName>
<UndertakeGov><![CDATA[公共工程委員會]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 范良銹]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月27日]]></Date_Created>
<GazetteId><![CDATA[工程技字第09800116501號]]></GazetteId>
<Title><![CDATA[行政院公共工程委員會公告：核准李曲原換發技師執業執照，依技師法第6條第1項第2款方式執行結構工程科技師業務]]></Title>
<TitleEnglish><![CDATA[PUBLIC CONSTRUCTION COMMISSION, EXECUTIVE YUAN Approval granted for re-certification of the professional engineer license held by an engineer named as Li Chu-yuan in performing Structural Engineering in accordance with Subparagraph 2, Paragraph 1, Article 6 of "Professional Engineer Act"]]></TitleEnglish>
<ThemeSubject><![CDATA[核准李曲原換發技師執業執照，依技師法第6條第1項第2款方式執行結構工程科技師業務，特此公告。]]></ThemeSubject>
<Keyword><![CDATA[技師;執業執照;結構工程科]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、技師姓名：李曲原
二、執業方式：技師法第6條第1項第2款
三、執業機構名稱：台灣世曦工程顧問股份有限公司
所   在   地：臺北市辛亥路2段185號28樓
四、技師科別證書字號：結構工程科  台工登字第10866號
五、業務範圍：如結構工程科執業範圍
六、執業執照字號：技執字第003145號
七、執照有效期間：自98年6月4日至102年6月3日止]]></Explain>
<Category><![CDATA[660]]></Category>
<Cake><![CDATA[872]]></Cake>
<Service><![CDATA[514]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch06/type5/gov51/num10/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:30%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.pcc.gov.tw/">行政院公共工程委員會</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span>年<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span>月<span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">27</span>日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">工程技字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09800116501</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主　　旨：</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">核准李曲原換發技師執業執照，依<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030022">技師法</a>第</span><span lang="EN-US">6</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條第</span><span lang="EN-US">1</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">項第</span><span lang="EN-US">2</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">款方式執行結構工程科技師業務，特此公告。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030022">技師法</a>第</span><span lang="EN-US">7</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">公告事項：</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">一、技師姓名：李曲原</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">二、執業方式：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1J0030022">技師法</a>第</span><span lang="EN-US">6</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">條第</span><span lang="EN-US">1</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">項第</span><span lang="EN-US">2</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">款</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">三、</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">執業機構名稱：台灣世曦工程顧問股份有限公司<o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="text-indent: -22.1pt; margin-left: 55.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">　　所&nbsp;&nbsp;   
                            在&nbsp;&nbsp; 地：臺北市辛亥路2段185號28樓<o:p>  
                            </o:p>  
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">四、技師科別證書字號：結構工程科　台工登字第10866號<o:p>
                            </o:p>  
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">五、業務範圍：如結構工程科執業範圍<o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">六、執業執照字號：技執字第003145號</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">七、執照有效期間：自</span><span lang="EN-US">98</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US">6</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US">4</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日至</span><span lang="EN-US">102</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US">6</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US">3</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日止</span><span lang="EN-US"><o:p>
                            </o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:0cm;
margin-left:0cm;margin-bottom:.0001pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">主任委員　范良銹</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="text-indent: 49pt; mso-char-indent-count: 6.2; mso-char-indent-size: 9.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; margin-bottom: 6.0pt"><font size="2"><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">本案依分層負責規定授權業務主管決行</span><o:p>
                            </o:p>
                            </o:p>
                            </span></font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30554]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規命令訂定、修正草案及廢止案之預告]]></Doc_Style_SName>
<Chapter><![CDATA[農業環保篇]]></Chapter>
<PubGov><![CDATA[農委會]]></PubGov>
<PubGovName><![CDATA[農業委員會]]></PubGovName>
<UndertakeGov><![CDATA[林務局]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 陳武雄]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[農林務字第0981700350號]]></GazetteId>
<Title><![CDATA[行政院農業委員會公告：預告「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」修正草案]]></Title>
<TitleEnglish><![CDATA[COUNCIL OF AGRICULTURE, EXECUTIVE YUAN Notice is hereby given, to commence a period of public comment for the draft amendment of the list of protected wildlife that require prior permission of the authorities before their live specimen can be traded，displayed or exhibited in public areas]]></TitleEnglish>
<ThemeSubject><![CDATA[預告修正「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」。]]></ThemeSubject>
<Keyword><![CDATA[野生動物保育;保育類野生動物;公共場所;買賣;禁售]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、修正機關：行政院農業委員會。
二、修正依據：野生動物保育法第三十五條第二項規定辦理。
三、「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」修正草案對照表如附件。本案另載於本會全球資訊網站（http://www.coa.gov.tw）及本會林務局網站（http://www.forest.gov.tw）。
四、本會依野生動物保育法第四條第二項規定，於本（九十八）年三月四日以農林務字第0九八一七00一八0號公告修正保育類野生動物名錄後，爰配合修正公告「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」。
五、對於本公告內容有任何意見或修正建議者，請於本公告刊登公報之日起7日內陳述意見或洽詢：
（一）承辦單位：本會林務局
（二）地址：10050台北市杭州南路1段2號
（三）電話：02-23515441轉657
（四）傳真：02-23217661
（五）電子郵件：service@forest.gov.tw]]></Explain>
<Category><![CDATA[720;780]]></Category>
<Cake><![CDATA[J33;A48;COZ]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch07/type3/gov62/num11/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><a href="http://www.coa.gov.tw/index_intro.php"><b>行政院農業委員會</b></a><b>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">農林務字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0981700350</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">主　　旨：</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">預告修正「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」。</span></font></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第一百五十一條第二項準用第一百五十四條第一項。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">公告事項：</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、 修正機關：行政院農業委員會。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、 修正依據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1M0120001">野生動物保育法</a>第三十五條第二項規定辦理。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、 
                            「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」修正草案對照表如附件。本案另載於本會全球資訊網站（</span><a href="http://www.coa.gov.tw"><span lang="EN-US">http://www.coa.gov.tw</span></a><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及本會林務局網站（</span><a href="http://www.forest.gov.tw"><span lang="EN-US">http://www.forest.gov.tw</span></a><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">本會依<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1M0120001">野生動物保育法</a>第四條第二項規定，於本（九十八）年三月四日以農林務字第○九八一七○○一八○號公告修正保育類野生動物名錄後，爰配合修正公告「非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類」。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">對於本公告內容有任何意見或修正建議者，請於本公告刊登公報之日起</span><span lang="EN-US">7</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">日內陳述意見或洽詢：</span></font></p>
                            <p class="0122" style="margin-left:66.25pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">承辦單位：本會林務局</span></font></p>
                            <p class="0122" style="margin-left:66.25pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">地址：</span><span lang="EN-US">10050</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">台北市杭州南路</span><span lang="EN-US">1</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">段</span><span lang="EN-US">2</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">號</span></font></p>
                            <p class="0122" style="margin-left:66.25pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電話：</span><span lang="EN-US">02-23515441</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">轉</span><span lang="EN-US">657</span></font></p>
                            <p class="0122" style="margin-left:66.25pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">傳真：</span><span lang="EN-US">02-23217661</span></font></p>
                            <p class="0122" style="margin-left:66.25pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電子郵件：</span><a href="mailto:service@forest.gov.tw"><span lang="EN-US">service@forest.gov.tw</span></a></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">主任委員　陳武雄</font></span></p>
                            <p class="021">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>非經主管機關同意，不得買賣或在公共場所陳列、展示之保育類野生動物之種類修正草案對照表</b></font></span></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依據野生動物保育法第三十五條第二項</font></span></p>
                            <p class="013"><img border="0" src="images/images001.gif" width="740" height="910"><img border="0" src="images/images002.gif" width="740" height="1030"><img border="0" src="images/images003.gif" width="740" height="1000"><img border="0" src="images/images004.gif" width="740" height="1026"><img border="0" src="images/images005.gif" width="740" height="1002"><img border="0" src="images/images006.gif" width="740" height="1027"><img border="0" src="images/images007.gif" width="740" height="1030"><img border="0" src="images/images008.gif" width="740" height="1004"><img border="0" src="images/images009.gif" width="740" height="1033"><img border="0" src="images/images010.gif" width="740" height="1001"><img border="0" src="images/images011.gif" width="740" height="1037"><img border="0" src="images/images012.gif" width="740" height="1033"><img border="0" src="images/images013.gif" width="740" height="1035"><img border="0" src="images/images014.gif" width="740" height="1034"><img border="0" src="images/images015.gif" width="740" height="1000"><img border="0" src="images/images016.gif" width="740" height="1030"><img border="0" src="images/images017.gif" width="740" height="1031"><img border="0" src="images/images018.gif" width="740" height="1033"><img border="0" src="images/images019.gif" width="740" height="1034"><img border="0" src="images/images020.gif" width="740" height="1003"><img border="0" src="images/images021.gif" width="740" height="1033"><img border="0" src="images/images022.gif" width="740" height="1028"><img border="0" src="images/images023.gif" width="740" height="1031"><img border="0" src="images/images024.gif" width="740" height="1026"><img border="0" src="images/images025.gif" width="740" height="1027"><img border="0" src="images/images026.gif" width="740" height="1028"><img border="0" src="images/images027.gif" width="740" height="1026"><img border="0" src="images/images028.gif" width="740" height="1029"><img border="0" src="images/images029.gif" width="740" height="1028"><img border="0" src="images/images030.gif" width="740" height="968"><img border="0" src="images/images031.gif" width="740" height="971"><img border="0" src="images/images032.gif" width="740" height="999"><img border="0" src="images/images033.gif" width="740" height="1025"><img border="0" src="images/images034.gif" width="740" height="1020"><img border="0" src="images/images035.gif" width="740" height="1018"><img border="0" src="images/images036.gif" width="740" height="1025"><img border="0" src="images/images037.gif" width="740" height="1030"><img border="0" src="images/images038.gif" width="740" height="1018"><img border="0" src="images/images039.gif" width="740" height="989"><img border="0" src="images/images040.gif" width="740" height="993"><img border="0" src="images/images041.gif" width="740" height="1034"><img border="0" src="images/images042.gif" width="740" height="1021"><img border="0" src="images/images043.gif" width="740" height="560"></p>
                            <p class="013">　</p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30558]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規命令訂定、修正草案及廢止案之預告]]></Doc_Style_SName>
<Chapter><![CDATA[農業環保篇]]></Chapter>
<PubGov><![CDATA[農委會]]></PubGov>
<PubGovName><![CDATA[農業委員會]]></PubGovName>
<UndertakeGov><![CDATA[林務局]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 陳武雄]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[農林務字第0981700351號]]></GazetteId>
<Title><![CDATA[行政院農業委員會公告：預告「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」修正草案]]></Title>
<TitleEnglish><![CDATA[COUNCIL OF AGRICULTURE, EXECUTIVE YUAN Notice is hereby given, to commence a period of public comment for the draft amendment of the list of endangered species and rare and valuable species that require prior permission of the authorities before their products can be traded, displayed or exhibited in public areas]]></TitleEnglish>
<ThemeSubject><![CDATA[預告修正「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」。]]></ThemeSubject>
<Keyword><![CDATA[野生動物保育;稀有動物(瀕臨絕種動物);公共場所;買賣;禁售]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、修正機關：行政院農業委員會。
二、修正依據：野生動物保育法第三十五條第二項規定辦理。
三、「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」修正草案對照表如附件。本案另載於本會全球資訊網站（http://www.coa.gov.tw）及本會林務局網站（http://www.forest.gov.tw）。
四、本會依野生動物保育法第四條第二項規定，於本（九十八）年三月四日以農林務字第0九八一七00一八0號公告修正保育類野生動物名錄後，爰配合修正公告「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」。
五、對於本公告內容有任何意見或修正建議者，請於本公告刊登公報之日起7日內陳述意見或洽詢：
（一）承辦單位：本會林務局
（二）地址：10050台北市杭州南路1段2號
（三）電話：02-23515441轉657
（四）傳真：02-23217661
（五）電子郵件：service@forest.gov.tw]]></Explain>
<Category><![CDATA[720;780]]></Category>
<Cake><![CDATA[J33;A48;COZ]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch07/type3/gov62/num12/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:25%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.coa.gov.tw/index_intro.php">行政院農業委員會</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">農林務字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0981700351</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">主　　旨：預告修正「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第一百五十一條第二項準用第一百五十四條第一項。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">公告事項：</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、修正機關：行政院農業委員會。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、修正依據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1M0120001">野生動物保育法</a>第三十五條第二項規定辦理。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」修正草案對照表如附件。本案另載於本會全球資訊網站（</span><span lang="EN-US"><a href="http://www.coa.gov.tw">http://www.coa.gov.tw</a></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及本會林務局網站（</span><span lang="EN-US"><a href="http://www.forest.gov.tw">http://www.forest.gov.tw</a></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、</span><span style="mso-tab-count: 1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">本會依<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1M0120001">野生動物保育法</a>第四條第二項規定，於本（九十八）年三月四日以農林務字第○九八一七○○一八○號公告修正保育類野生動物名錄後，爰配合修正公告「非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生動物產製品之種類」。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五、對於本公告內容有任何意見或修正建議者，請於本公告刊登公報之日起</span><span lang="EN-US">7</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">日內陳述意見或洽詢：</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">承辦單位：本會林務局</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">地址：</span><span lang="EN-US">10050</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">台北市杭州南路</span><span lang="EN-US">1</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">段</span><span lang="EN-US">2</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">號</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電話：</span><span lang="EN-US">02-23515441</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">轉</span><span lang="EN-US">657</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">傳真：</span><span lang="EN-US">02-23217661</span></font></p>
                            <p class="0122" style="text-indent: -22.1pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;   
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">電子郵件：</span><a href="mailto:service@forest.gov.tw"><span lang="EN-US">service@forest.gov.tw</span></a></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">主任委員　陳武雄</font></span></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm">　</p>
                            <p class="021" style="margin-top:1.0gd;margin-right:0cm;margin-bottom:.5gd;
margin-left:0cm;line-height:normal"><font size="2"><b><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;letter-spacing:-.05pt">非經主管機關同意，不得買賣或在公共場所陳列、展示之瀕臨絕種及珍貴稀有野生</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">動物產製品之種類修正草案對照表</span></b></font></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依據野生動物保育法第三十五條第二項</font></span></p>
                            <p style="text-indent: 0; margin-left: 0"><img border="0" src="images/images001.gif" width="740" height="589"><img border="0" src="images/images002.gif" width="740" height="1028"><img border="0" src="images/images003.gif" width="740" height="999"><img border="0" src="images/images004.gif" width="740" height="1027"><img border="0" src="images/images005.gif" width="740" height="1031"><img border="0" src="images/images006.gif" width="740" height="1000"><img border="0" src="images/images007.gif" width="740" height="1025"><img border="0" src="images/images008.gif" width="740" height="1033"><img border="0" src="images/images009.gif" width="740" height="1034"><img border="0" src="images/images010.gif" width="740" height="1002"><img border="0" src="images/images011.gif" width="740" height="1033"><img border="0" src="images/images012.gif" width="740" height="1005"><img border="0" src="images/images013.gif" width="740" height="1006"><img border="0" src="images/images014.gif" width="740" height="1034"><img border="0" src="images/images015.gif" width="740" height="999"><img border="0" src="images/images016.gif" width="740" height="1031"><img border="0" src="images/images017.gif" width="740" height="999"><img border="0" src="images/images018.gif" width="740" height="1033"><img border="0" src="images/images019.gif" width="740" height="1034"><img border="0" src="images/images020.gif" width="740" height="1032"><img border="0" src="images/images021.gif" width="740" height="1033"><img border="0" src="images/images022.gif" width="740" height="1027"><img border="0" src="images/images023.gif" width="740" height="1025"><img border="0" src="images/images024.gif" width="740" height="1029"><img border="0" src="images/images025.gif" width="740" height="1026"><img border="0" src="images/images026.gif" width="740" height="1026"><img border="0" src="images/images027.gif" width="740" height="1031"><img border="0" src="images/images028.gif" width="740" height="1027"><img border="0" src="images/images029.gif" width="740" height="1026"><img border="0" src="images/images030.gif" width="740" height="1029"><img border="0" src="images/images031.gif" width="740" height="1031"><img border="0" src="images/images032.gif" width="740" height="1020"><img border="0" src="images/images033.gif" width="740" height="990"><img border="0" src="images/images034.gif" width="740" height="1025"><img border="0" src="images/images035.gif" width="740" height="998"><img border="0" src="images/images036.gif" width="740" height="1018"><img border="0" src="images/images037.gif" width="740" height="1018"><img border="0" src="images/images038.gif" width="740" height="1020"><img border="0" src="images/images039.gif" width="740" height="1022"><img border="0" src="images/images040.gif" width="740" height="1024"><img border="0" src="images/images041.gif" width="740" height="1032"><img border="0" src="images/images042.gif" width="740" height="560"></p>
                            <p style="text-indent: 0; margin-left: 0">　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30562]]></MetaId>
<Doc_Style_LName><![CDATA[法規]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[中央法規標準法第3條之7種命令]]></Doc_Style_SName>
<Chapter><![CDATA[衛生勞動篇]]></Chapter>
<PubGov><![CDATA[衛生署]]></PubGov>
<PubGovName><![CDATA[行政院衛生署]]></PubGovName>
<UndertakeGov><![CDATA[行政院衛生署]]></UndertakeGov>
<Officer_name><![CDATA[署長 葉金川]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[衛署藥字第0980316265號]]></GazetteId>
<Title><![CDATA[行政院衛生署令：訂定「藥品生體可用率及生體相等性試驗準則」]]></Title>
<TitleEnglish><![CDATA[DEPARTMENT OF HEALTH, EXECUTIVE YUAN Order is hereby given, for the promulgation of "Regulations of Bioavailability and Bioequivalence Studies of Pharmaceuticals"]]></TitleEnglish>
<ThemeSubject><![CDATA[訂定「藥品生體可用率及生體相等性試驗準則」。]]></ThemeSubject>
<Keyword><![CDATA[藥物(藥品);生體可用率(BA);生體相等性(BE);藥品查驗登記;製藥業(藥廠);藥商;注射劑;學名藥;口服劑;人體試驗;臨床試驗;抽血;驗尿(尿液檢驗，尿液篩檢，尿液採驗);試驗與實驗;評估]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[訂定「藥品生體可用率及生體相等性試驗準則」。
    附「藥品生體可用率及生體相等性試驗準則」]]></Explain>
<Category><![CDATA[840]]></Category>
<Cake><![CDATA[J32;B21;B24]]></Cake>
<Service/>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch08/type1/gov70/num13/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width: 775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格" height="115">
					<tr>
						<td style="width: 20%" height="12">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.doh.gov.tw/cht2006/index_populace.aspx">行政院衛生署</a>令</b></font></span>
						</td>
						<td style="width: 601 px" height="12">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中國民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">衛署藥字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980316265</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width: 733px" height="51">
                            <p class="0131-1" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">訂定「藥品生體可用率及生體相等性試驗準則」。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0132-2" style="margin-left:33.15pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">附「藥品生體可用率及生體相等性試驗準則」</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">署　　長　葉金川</span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>藥品生體可用率及生體相等性試驗準則</b></font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　一　章</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">總則</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　一　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本準則依藥事法第四十二條第二項規定訂定之。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　二　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">藥品生體可用率與生體相等性及有關試驗之執行，應符合本準則之規定；本準則未規定者，依藥品優良臨床試驗準則、藥品查驗登記審查準則及其他有關法令之規定。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　三　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本準則用詞定義如下：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">生體可用率（</span><span lang="EN-US">Bioavailability</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）：指藥品有效成分由製劑中吸收進入全身血液循環或作用部位之速率（</span><span lang="EN-US">rate</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）與程度（</span><span lang="EN-US">extent</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）之指標。如係不具全身性吸收之藥品，則指以有效成分到達作用部位之速率與程度作評估之指標。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">藥劑相等品（</span><span lang="EN-US">Pharmaceutical     
                            Equivalents</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）：指具有相同有效成分及相等含量之相同劑型之藥品，其成品檢驗規格符合相同之藥典或其他經中央衛生主管機關認可之品質規定者。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">藥劑替代品（</span><span lang="EN-US">Pharmaceutical     
                            Alternatives</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）：指具有相同有效成分或其前驅藥物（</span><span lang="EN-US">precursor</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">），惟劑型、含量、鹽基或酯類未必相同之藥品，其成品檢驗規格符合相同之藥典或其他經中央衛生主管機關認可之品質規定者。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">生體相等性（</span><span lang="EN-US">Bioequivalence</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）：指二個藥劑相等品或藥劑替代品，於適當研究設計下，以相同條件、相同莫耳劑量（</span><span lang="EN-US">molar     
                            dose</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）給與人體時，具有相同之生體可用率。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　四　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗之前，藥商應向中央衛生主管機關申請核定計畫，其試驗計畫書之內容，應符合藥品優良臨床試驗準則之規定。但學名藥之生體可用率及生體相等性試驗計畫書，得免事先申請。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　五　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">依本準則申請核定各種試驗之計畫與報告，應繳納費用，並填具中央衛生主管機關所定之申請書表，依書表所載事項備齊相關資料，送交中央衛生主管機關審核。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項所稱之申請書表，包括藥品生體可用率試驗計畫書申請表、藥品生體相等性試驗計畫書申請表、藥品生體可用率試驗報告書申請表、藥品生體相等性試驗報告書申請表、溶離率曲線比對報告申請表及其他與申請程序有關之書表格式。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　六　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">試驗報告，應依中央衛生主管機關規定之方式撰寫，並檢附有關試驗之完整內容及試驗資料提交審核。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span style="mso-tab-count: 1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">申請人應以書面聲明並確認執行試驗之藥品即為查驗登記之藥品。試驗數據之品質與完整性之最終責任，應由申請人負責。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　七　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">非經血管內給藥且能發生全身性作用（</span><span lang="EN-US">systemic     
                            action</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之各種製劑，如有下列情形之一者，應執行生體可用率或生體相等性試驗：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新藥及藥品查驗登記審查準則規定應執行者。但申請人如有提出資料經中央衛生主管機關審查認可者，得免執行生體可用率或生體相等性試驗。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">非監視藥品經中央衛生主管機關認定應執行生體可用率或生體相等性試驗者。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">申請查驗登記之學名藥，如含有列入新藥監視之成分者（含監視中及監視期滿成分），應檢附生體相等性試驗資料。但經中央衛生主管機關認可之品項，得免檢附。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　八　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">符合下列情形之一者，得免除生體相等性試驗：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、血管內給藥注射劑。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、學名藥口服溶液劑，如其賦形劑不影響主成分吸收者。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">血管外給藥注射劑，如學名藥注射溶液劑與原開發廠產品或藥典收載規格之酸鹼值（</span><span lang="EN-US">pH</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">值）相同，且除防腐劑、緩衝劑外之配方均相同者。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">四、供吸入之氣體或蒸氣。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">五、皮膚外用製劑之學名藥。但不含需皮下及皮內吸收之製劑。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">六、眼用、耳用製劑之學名藥。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">七、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">同一口服固體製劑之高、低劑量產品查驗登記、或已執行生體相等性試驗且經核准上市後之變更登記，經中央衛生主管機關認可得以溶離曲線比對試驗替代生體相等性試驗者。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">八、其他經中央衛生主管機關依申請人檢附之資料核定得免除者。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p>    
                            </font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">第　二　章</font></span><font size="2"><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">生體可用率及生體相等性試驗</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　九　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗前，宜先進行預試驗，以確定所使用之劑量、抽血或取尿之量、與取樣時間間隔是否恰當、分析方法是否可行，並將所得之數據處理完畢後，始進入主試驗。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行試驗之藥品（含受試藥品及對照藥品），應先完成一般成品檢驗，並宜執行溶離曲線比對試驗。受試藥品與對照藥品之含量差異，不宜超過百分之五。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">供試驗之藥品生產批量，以最低不得少於一萬個劑型單位（</span><span lang="EN-US">dosage     
                            units</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）為原則，如有特殊情況，不在此限。但仍不得低於生產批量之十分之一。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行試驗，應聘有藥動學專業人員、適當之分析人員及醫師（或與教學醫院合作），並具備經中央衛生主管機關認定之適當臨床試驗及分析處所。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項藥動學專業人員，應具有藥學相關碩士學位以上，並有藥動學之研究或發表者。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第　十　條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗，其受試者之選擇，應符合人體試驗倫理規範，除有特殊情況外，原則上以自願健康成年人為對象，並考慮其性別、年紀與族群等因素，於計畫書中應詳述納入及排除條件，並以一般實驗室檢查（</span><span lang="EN-US">standard     
                            laboratory tests</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）、疾病史（</span><span lang="EN-US">medical     
                            history</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及理學檢查（</span><span lang="EN-US">physical     
                            examination</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）等項目篩選，且應就個別藥品之特性作個別醫學檢查項目之要求（如心電圖等）。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">受試者之人數，至少應有十二名，且應用適當之檢定力計算（</span><span lang="EN-US">appropriate     
                            power calculations</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）以評估受試者之人數。試驗進行前，應經人體試驗委員會之同意，並取得受試者同意書。受試者同意書之內容，應依藥品優良臨床試驗準則之規定，且宜投保。受試者之臨床試驗間隔，應符合捐血者健康標準之規定，以保障受試者之權益。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第</span>&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十一</span>&nbsp;     
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">選擇執行生體相等性試驗之對照藥品，規定如下：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">監視新藥成分之對照藥品，應選用有資料證明係原開發廠之產品或中央衛生主管機關核准上市之第一家產品。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、非監視新藥成分之對照藥品，應選用有資料證明係符合下列情形之一者：</font></span></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">原開發廠之產品。</span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">已知生體可用率之國內市售品。</span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">與原開發廠之產品具生體相等性或證明臨床有效性之產品。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、除前二款規定之情形外，其他經中央衛生主管機關認可之對照藥品。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十二&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">選擇執行生體可用率試驗之對照藥品，其主成分或具療效成分（</span><span lang="EN-US">therapeutic     
                            moiety</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">）應符合下列情形之一：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、靜脈注射劑。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、口服溶液劑（</span><span lang="EN-US">solution</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）或懸液劑（</span><span lang="EN-US">suspension</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、原開發廠之產品或已知生體可用率之國內市售品。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">四、除前三款之情形外，具有確實之科學根據且經中央衛生主管機關認可者。</font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十三&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗之評估標的，得以血、尿中之藥品或其代謝物濃度（以下簡稱血中濃度、尿中濃度）、或以適當之藥理反應及臨床效應為對象。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第</span>&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十四&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">生體可用率及生體相等性試驗之設計，應依受試藥品及對照藥品採用隨機之雙向或多向交叉設計（</span><span lang="EN-US">randomized     
                            two or more way crossover designs</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">）或拉丁方格設計（</span><span lang="EN-US">Latin     
                            Square Designs</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">），以減低因受試者間所造成之差異。如無法執行交叉設計之試驗時，得採用平行設計（</span><span lang="EN-US">Parallel     
                            Designs</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。但平行設計之試驗，其各組受試人數應適當設定。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">健康受試者於參加試驗前，應禁服任何藥品二週以上。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">服藥前，應禁食十小時以上；如係執行食物影響試驗（</span><span lang="EN-US">Food     
                            Effect Study</span><span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）者，在指給與食物前，應禁食十小時以上。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">服藥後，應再繼續禁食四小時。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第</span>&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十五</span>&nbsp;     
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗之採樣與時間，規定如下：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">抽血時間至少應持續至到達最高血中濃度（</span><span lang="EN-US">Cmax</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）後三倍以上之藥品排除半衰期；取尿時間應為排除半衰期之七倍以上。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、採樣次數，應以足可說明藥品於體內之吸收、分布及排除為標準。</font></span></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">於交叉試驗中，其二次處理期間（</span><span lang="EN-US">treatment     
                            period</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）之藥品洗除期間（</span><span lang="EN-US">washout     
                            period</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">），原則上至少應為該藥品排除半衰期之五倍。但服藥前之血中濃度不得超過最高血中濃度（</span><span lang="EN-US">Cmax</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">）之百分之五。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項第三款所稱二次處理期間（</span><span lang="EN-US">treatment     
                            period</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之藥品洗除期間（</span><span lang="EN-US">washout     
                            period</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">），係指完成第一次使用藥品之最後一次採樣後，迄第二次使用藥品時止之間隔時間。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">多劑量試驗之採樣與時間，得不受前二項規定之限制。但其採樣時間，應達到足以測定其穩定狀態（</span><span lang="EN-US">steady     
                            state</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之血中濃度。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十六</span>&nbsp;     
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">生體可用率及生體相等性試驗之檢體分析，應依循非臨床試驗優良操作規範，並符合下列規定：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">使用之分析方法，應能測得原始試驗藥品或其代謝物，並有適當之最低可測得濃度。如以其代謝物為分析標的者，應事先經中央衛生主管機關認可。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">生體含量分析方法確效（</span><span lang="EN-US">Bioanalytical     
                            Method Validation</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;    
mso-hansi-font-family:&quot;Times New Roman&quot;">），應涵蓋精密度（</span><span lang="EN-US">Precision</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、準確度（</span><span lang="EN-US">Accuracy</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、選擇性（</span><span lang="EN-US">Selectivity</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、基質效應（</span><span lang="EN-US">Martrix     
                            Effect</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、檢體之安定性（</span><span lang="EN-US">Stability</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）及最低定量濃度（</span><span lang="EN-US">Lower     
                            Limit of Quantification</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;    
mso-hansi-font-family:&quot;Times New Roman&quot;">）等資料，並應注意系統適用性（</span><span lang="EN-US">System     
                            Suitability</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。檢體之安定性，應包括冷凍與解凍安定性（</span><span lang="EN-US">Freeze     
                            and Thaw Stability</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）、短期室溫安定性（</span><span lang="EN-US">Short     
                            Term Temperature Stability</span><span style="font-family:    
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）、長期安定性（</span><span lang="EN-US">Long     
                            Term Stability</span><span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）、貯液安定性（</span><span lang="EN-US">Stock     
                            Solution Stability</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）、分析期間安定性（</span><span lang="EN-US">Post     
                            Preparative Stability</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。但如有特殊原因，申請人說明理由並檢附相關文獻及證明資料，經中央衛生主管機關認可者，不在此限。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">準確度之測定，其各濃度平均值應在理論值之百分之十五範圍內，且最低定量濃度應在理論值之百分之二十範圍內。精密度之測定，其每個濃度之變異係數（</span><span lang="EN-US">Coefficient     
                            of Variation</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）不得超過百分之十五，且最低定量濃度之變異係數不得超過百分之二十。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十七&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">執行生體可用率及生體相等性試驗之數據，應包括各受試者之原始資料及得自不同評估標的所取得之重要生體可用率參數，並符合下列規定：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">如以血中藥之濃度為評估標的者，應比較下列各參數，必要時，得依藥動學原理比較其他有關參數：</span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">速放劑型（</span><span lang="EN-US">Immediate     
                            Release Dosage Forms</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">）之單劑量試驗：最高血中濃度（</span><span lang="EN-US">Cmax</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、曲線下總面積。對半衰期長且分布及清除率呈現個體內變異性低之藥品，必要時，事先提出申請經核定者，得使用截平曲線下總面積（</span><span lang="EN-US">Truncated     
                            AUC</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">速放劑型之多劑量試驗：穩定狀態之最高血中濃度（</span><span lang="EN-US">Cmax,<span style="mso-font-width:50%"> 
                            </span>ss</span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及穩定狀態之一個服藥間隔曲線下總面積（</span><span lang="EN-US">AUC<sub>0-</sub></span><sub><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-text-raise: -1.0pt">τ</span><span lang="EN-US">,     
                            ss</span></sub><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">，τ：一個給藥間隔時間）。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">三</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">控釋劑型之多劑量試驗：穩定狀態之最高血中濃度（</span><span lang="EN-US">Cmax,<span style="mso-font-width:50%"> 
                            </span>ss</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">）及穩定狀態之一個服藥間隔曲線下總面積（</span><span lang="EN-US">AUC<sub>0-</sub></span><sub><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-text-raise: -1.0pt">τ</span><span lang="EN-US">,     
                            ss</span></sub><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">，τ：一個給藥間隔時間）。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="033" style="margin-left:110.05pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">四</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">控釋劑型之單劑量試驗（應併執行高脂高卡路</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">里之食物影響試驗）：最高血中濃度（</span><span lang="EN-US">Cmax</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">）、曲線下總面積。對半衰期長且分布及清除率呈現個體內變異性低之藥品，必要時，事先提出申請經核定者，得使用截平曲線下總面積（</span><span lang="EN-US">Truncated     
                            AUC</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">如以尿液為評估標的者，應比較藥在尿中各時段所測得之排出量及由起始時間至試驗終止時間尿中排出藥之累積量之值。必要時，得依藥動學原理比較其他有關參數。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">如試驗係屬觀察藥理效應，其藥理反應須在與劑量成正比之範圍內，並應比較藥理效應強度與發生時間之關係，包括其起點、終點及久暫等。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項第一款第一目及第四目之曲線下總面積，應包括採時間零至無限大之曲線下總面積（</span><span lang="EN-US">AUC<sub>0-</sub></span><sub><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;
mso-text-raise:-1.5pt">∞</span></sub><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及時間零至最終採血點時間之曲線下總面積（</span><span lang="EN-US">AUC<sub>0-t</sub></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">，</span><span lang="EN-US">t</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">：最終採血點時間），且時間零至最終採血點時間之曲線下總面積（</span><span lang="EN-US">AUC<sub>0-t</sub></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）除以時間零至無限大之曲線下總面積（</span><span lang="EN-US">AUC<sub>0-</sub></span><sub><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;
mso-text-raise:-1.5pt">∞</span></sub><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之比值不得小於零點八。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">各有關數據之統計比較結果，應列圖表說明。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第</span>&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十八</span>&nbsp;     
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">參與統計分析之生體可用率參數，應取對數值先進行變異數分析（</span><span lang="EN-US">ANOVA</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">），其α值設定為零點零五，再計算藥品效應（</span><span lang="EN-US">Treatment     
                            Effect</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">）之百分之九十信賴區間（</span><span lang="EN-US">90%     
                            Confidence Interval</span><span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">參與統計分析之生體可用率參數，全部以對數值計算百分之九十信賴區間，其取反對數值之百分之九十信賴區間，原則上應於零點八至一點二五之間。但經事先申請核定，且於認可安全性及有效性下並符合國際規定時，最高血中濃度（</span><span lang="EN-US">Cmax</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">）得放寬至零點七五至一點三三之間。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">十九&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">特殊劑型（如微脂粒、經皮吸收、吸入性等製劑）之生體相等性試驗及生體可用率試驗報告，由中央衛生主管機關視其品質、規格，依個案情形審核。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第&nbsp;</span> <span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">二十&nbsp;</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">條</span><span style="mso-tab-count:1" lang="EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二種藥品之生體相等性比較，得以生體可用率試驗連同臨床試驗替代。但原則上以生體相等性試驗為優先。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt;mso-pagination:widow-orphan"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">如以生體可用率試驗連同臨床試驗替代者，所執行之臨床試驗，應具有統計顯著（</span><span lang="EN-US">Statistical     
                            Significance</span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之意義。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p>    
                            </font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">第　三　章</font></span><font size="2"><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">溶離曲線比對試驗</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十一條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行溶離曲線比對試驗，應符合下列規定：</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">依執行試驗之目的，選擇適當之對照藥品。執行試驗之藥品，應有配方、製造及品管資料。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">受試藥品與對照藥品之溶離曲線比對，應於同一試驗條件下進行，並應具備適當之試驗條件，如使用網籃裝置（</span><span lang="EN-US">Basket     
                            Method</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）五十至一百轉速或攪拌槳裝置（</span><span lang="EN-US">Paddle     
                            Method</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）五十至七十五轉速，並於模擬胃腸道酸鹼值（</span><span lang="EN-US">pH</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">值）或至少三個足以模擬胃腸道（</span><span lang="EN-US">pH</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">值之範圍應於一點二至六點八之間）之溶媒，於攝氏三十七度進行試驗。</span></font></p>
                            <p class="032" style="margin-left:99.25pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三、</span><span style="mso-tab-count:1" lang="EN-US"> 
                            </span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">如有特殊原因，須於其他試驗條件下進行者，應檢附科學資料，由中央衛生主管機關審定。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十二條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">執行溶離曲線比對試驗所用之設備及分析方法，應檢具所用溶離裝置之系統適用性（</span><span lang="EN-US">System     
                            Suitability</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）及定量分析方法確效（</span><span lang="EN-US">Analytical     
                            Methods Validation</span><span style="font-family:新細明體;    
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）之資料。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十三條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">以溶離曲線比對試驗替代生體相等性試驗時，執行溶離曲線比對試驗所比對之受試藥品與對照藥品數量，應各有至少十二個劑型單位（</span><span lang="EN-US">dosage     
                            units</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">），且試驗應有足夠之採樣點，並有溶離相似性（</span><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">值）或其他適當之統計結果。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">前項採樣第一時間點受試藥品與對照藥品之變異係數不得超過百分之二十，其他時間點之變異係數不得超過百分之十。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">第一項受試藥品與對照藥品溶出百分之八十五以後，僅得取一點計算溶離相似性（</span><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">值）；十五分鐘內溶出百分之八十五以上藥物者，免計算溶離相似性（</span><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">值）。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span lang="EN-US"><span style="mso-tab-count:2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  
                            &nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">溶離相似性（</span><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">值）之計算方式及結果認定，規定如附件。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p>    
                            </font></span></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">第　四　章</font></span><font size="2"><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">附則</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十四條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">申請人應自行或委由試驗執行機構保存執行生體可用率及生體相等性試驗之藥品（含受試藥品及對照藥品），且足夠留樣至報告核准後至少五年，並配合衛生主管機關覆驗、查核。試驗報告未獲核准者，亦同。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十五條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">經核准之各種試驗計畫與報告，非經中央衛生主管機關同意，不得變更。</span></font></p>
                            <p class="031" style="margin-left:55.0pt;text-indent:-55.0pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第二十六條</span><span lang="EN-US"><span style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="mso-tab-count:1">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
                            </span></span><span style="font-family:新細明體;
mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">本準則自發布日施行。</span></font></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2"><b><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">附件　溶離相似性（</span><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">值）之計算方式及結果認定</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman"></span></b></font></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt" align="center"><span lang="EN-US" style="font-size:12.0pt;font-family:
&quot;Times New Roman&quot;;mso-fareast-font-family:新細明體;mso-font-kerning:1.0pt;
mso-ansi-language:EN-US;mso-fareast-language:ZH-TW;mso-bidi-language:AR-SA"><span style="mso-text-raise:-48.0pt"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:165.75pt;
 height:95.25pt' o:ole="">
 <v:imagedata src="file:///C:/DOCUME~1/linda/LOCALS~1/Temp/msoclip1/05/clip_image001.wmz"
  o:title=""/>
</v:shape><![endif]-->
                            <img src="images/images005.gif" v:shapes="_x0000_i1025" width="221" height="127"></span><!--[if gte mso 9]><xml> 
 <o:OLEObject Type="Embed" ProgID="Equation.3" ShapeID="_x0000_i1025"
  DrawAspect="Content" ObjectID="_1300102448">
 </o:OLEObject>
</xml><![endif]-->
                            </span></p>
                            <p class="0221" style="margin-left:0cm;text-indent:0cm;mso-char-indent-count:
0;mso-char-indent-size:0cm"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">上列公式</span><span lang="EN-US">f<span style="mso-font-width:33%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">溶離相似值，</span><span lang="EN-US">n</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">為溶出之採樣點數，</span><span lang="EN-US" style="font-family:標楷體"><span style="mso-text-raise:-5.0pt"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:22.5pt;
 height:18pt' o:ole="">
 <v:imagedata src="file:///C:/DOCUME~1/linda/LOCALS~1/Temp/msoclip1/06/clip_image001.wmz"
  o:title=""/>
</v:shape><![endif]-->
                            <img src="images/images001.gif" width="30" height="24" align="middle" v:shapes="_x0000_i1025"></span><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.3" ShapeID="_x0000_i1025"
  DrawAspect="Content" ObjectID="_1300103186">
 </o:OLEObject>
</xml><![endif]-->
                            </span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">係對照藥品於</span><span lang="EN-US">t</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">時間點之平均溶出百分比，</span><span lang="EN-US" style="font-family:標楷體"><span style="mso-text-raise:-5.0pt"><!--[if gte vml 1]><v:shape
 id="_x0000_i1026" type="#_x0000_t75" style='width:21.75pt;height:18pt' o:ole="">
 <v:imagedata src="file:///C:/DOCUME~1/linda/LOCALS~1/Temp/msoclip1/06/clip_image003.wmz"
  o:title=""/>
</v:shape><![endif]-->
                            <img src="images/images002.gif" width="29" height="24" align="middle" v:shapes="_x0000_i1026"></span><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.3" ShapeID="_x0000_i1026"
  DrawAspect="Content" ObjectID="_1300103187">
 </o:OLEObject>
</xml><![endif]-->
                            </span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">係受試藥品於</span><span lang="EN-US">t</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">時間點之平均溶出百分比。</span></font></p>
                    <p class="0221" style="margin-left:0cm;text-indent:0cm;mso-char-indent-count:
0;mso-char-indent-size:0cm"><span lang="EN-US"><font size="2">In this equation <i>f</i>   
                            <sub>2</sub> is the similarity factor, n is the   
                            number of time points,</font></span><font size="2"><span lang="EN-US" style="font-family:標楷體">   
                            <span style="mso-text-raise:-5.0pt"><!--[if gte vml 1]><v:shape  
 id="_x0000_i1027" type="#_x0000_t75" style='width:22.5pt;height:18pt' o:ole="">
 <v:imagedata src="file:///C:/DOCUME~1/linda/LOCALS~1/Temp/msoclip1/06/clip_image001.wmz"
  o:title=""/>
</v:shape><![endif]-->
                            <img src="images/images003.gif" width="30" height="24" align="middle" v:shapes="_x0000_i1027"></span><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.3" ShapeID="_x0000_i1027"
  DrawAspect="Content" ObjectID="_1300103188">
 </o:OLEObject>
</xml><![endif]-->
                            <span style="mso-spacerun: yes">&nbsp;</span></span><span lang="EN-US">is   
                            the mean percent drug dissolved of e.g. a reference   
                            product, and <span style="mso-text-raise:-5.0pt"><!--[if gte vml 1]><v:shape id="_x0000_i1028"  
 type="#_x0000_t75" style='width:21.75pt;height:18pt' o:ole="">
 <v:imagedata src="file:///C:/DOCUME~1/linda/LOCALS~1/Temp/msoclip1/06/clip_image003.wmz"
  o:title=""/>
</v:shape><![endif]-->
                            <img src="images/images004.gif" width="29" height="24" align="middle" v:shapes="_x0000_i1028"></span><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.3" ShapeID="_x0000_i1028"
  DrawAspect="Content" ObjectID="_1300103189">
 </o:OLEObject>
</xml><![endif]-->
                            <span style="mso-spacerun: yes">&nbsp;</span>is the   
                            mean percent drug dissolved of e.g. a test product.</span></font></p>  
                          <p class="0221" style="margin-left:0cm;text-indent:0cm;mso-char-indent-count:
0;mso-char-indent-size:0cm"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p>  
                            </font></span></p>
                            <p class="0221" style="margin-left:0cm;text-indent:0cm;mso-char-indent-count:
0;mso-char-indent-size:0cm"><font size="2"><span lang="EN-US">f<span style="mso-font-width:50%"> 
                            </span><sub>2</sub></span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">值≧</span><span lang="EN-US">50</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">，為認定受試藥品及對照藥品溶離曲線比對相似之必要條件。</span></font></p>
                            <p class="031"><span lang="EN-US"><font size="2">&nbsp;<o:p>
                            </o:p>  
                            </font></span></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt"><font size="2">　</font></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30557]]></MetaId>
<Doc_Style_LName><![CDATA[行政規則]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[行政程序法第159條第2項第2款]]></Doc_Style_SName>
<Chapter><![CDATA[衛生勞動篇]]></Chapter>
<PubGov><![CDATA[衛生署]]></PubGov>
<PubGovName><![CDATA[中央健康保險局]]></PubGovName>
<UndertakeGov><![CDATA[行政院衛生署中央健康保險局]]></UndertakeGov>
<Officer_name><![CDATA[總經理 朱澤民]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[健保審字第0980007217號]]></GazetteId>
<Title><![CDATA[中央健康保險局令：修正「全民健康保險藥品給付規定—第9章抗癌瘤藥物 Antineoplastics drugs 9.31. Sunitinib（如Sutent）給付規定」，自98年5月1日生效]]></Title>
<TitleEnglish><![CDATA[BUREAU OF NATIONAL HEALTH INSURANCE Order is hereby given, for the revision on Chapter 9 of "Directions of Drug Restricted Benefit for National Health Insurance"- the medical coverage of drugs acting on Antineoplastics drugs 9.31. Sunitinib（i.e. Sutent）(revised directions take into force from 1st, May 2009)]]></TitleEnglish>
<ThemeSubject><![CDATA[修正「全民健康保險藥品給付規定—第9章 抗癌瘤藥物 Antineoplastics drugs 9.31. Sunitinib（如Sutent）」給付規定，並自中華民國九十八年五月一日生效。]]></ThemeSubject>
<Keyword><![CDATA[全民健康保險(全民健保);藥品給付;藥物管制;抗癌瘤藥物;癌症(惡性腫瘤);審查]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[修正「全民健康保險藥品給付規定—第9章 抗癌瘤藥物 Antineoplastics drugs 9.31. Sunitinib（如Sutent）」給付規定，並自中華民國九十八年五月一日生效。
　附修正「全民健康保險藥品給付規定—第9章 抗癌瘤藥物 Antineoplastics drugs 9.31. Sunitinib（如Sutent）」給付規定]]></Explain>
<Category><![CDATA[820]]></Category>
<Cake><![CDATA[J38;B21;B4Z]]></Cake>
<Service><![CDATA[B1Z]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch08/type2/gov70/num14/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><a href="http://www.nhi.gov.tw/"><b>中央健康保險局</b></a><b>令</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">健保審字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980007217</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="0131-1" style="text-indent: -30pt; margin-left: 30pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">修正「全民健康保險藥品給付規定－第</span><span lang="EN-US">9</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">章　抗癌瘤藥物</span><span lang="EN-US">Antineoplastics 
                            drugs 9.31. Sunitinib</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">（如</span><span lang="EN-US">Sutent</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">）」給付規定，並自中華民國九十八年五月一日生效。</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0132-2" style="margin-left:33.15pt;text-indent:-22.1pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">附修正「全民健康保險藥品給付規定－第</span><span lang="EN-US">9</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">章　抗癌瘤藥物</span><span lang="EN-US">Antineoplastics 
                            drugs 9.31. Sunitinib</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">（如</span><span lang="EN-US">Sutent</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">）」給付規定</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">總</span> 
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">經</span> 
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">理　朱澤民</span><span lang="EN-US"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="021">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>全民健康保險藥品給付規定修正規定</b></font></span></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">第</span><span lang="EN-US">9</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">章　抗癌瘤藥物</span><span lang="EN-US">Antineoplastics 
                            drugs</span></font></p>
                            <p class="0221" style="text-indent: -22.1pt; margin-left: 22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">　　　　　　　　　　　　　　　　　　　（自</font></span><font size="2"><span lang="EN-US">98</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">年</span><span lang="EN-US">5</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">月</span><span lang="EN-US">1</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">日生效）</span></font></p>
                            <table border="1" cellspacing="0" cellpadding="0" style="border-collapse:collapse;
 mso-table-layout-alt:fixed;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0cm 1.4pt 0cm 1.4pt">
                              <tr style="height:5.65pt">
                                <td width="304" valign="top" style="width:227.85pt;border:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="044-1" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:24.5pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">修正後給付規定</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="304" valign="top" style="width:227.9pt;border:solid windowtext .5pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="044-1" align="center" style="margin-top:0cm;margin-right:2.4pt;
  margin-bottom:0cm;margin-left:24.5pt;margin-bottom:.0001pt;text-align:center;
  text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">原給付規定</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                              <tr style="height:5.65pt">
                                <td width="304" valign="top" style="width:227.85pt;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0cm 1.4pt 0cm 1.4pt;
  height:5.65pt">
                                  <p class="044-1" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:24.5pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US" style="mso-bidi-font-weight:bold">9.31. 
                                  　Sunitinib</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;;mso-bidi-font-weight:bold">（如</span><span lang="EN-US" style="mso-bidi-font-weight:bold">Sutent</span><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;
  mso-bidi-font-weight:bold">）</span><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">：（</span><span lang="EN-US">98/2/1</span><u><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">、</span><span lang="EN-US">98/5/1</span></u><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）</span><span lang="EN-US" style="mso-bidi-font-weight:bold"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="text-indent: -20pt; margin-left: 50pt; margin-right: 2.4pt; margin-top: 0cm; margin-bottom: .0001pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">１、</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">限用於以</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以下（含）／天治療期間出現疾病惡化或對該藥出現不能忍受之腸胃道間質腫瘤。</span><span lang="EN-US" style="mso-font-kerning: 0pt"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="text-indent: -20pt; margin-left: 50pt; margin-right: 2.4pt; margin-top: 0cm; margin-bottom: .0001pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">２、</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">若使用</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以上／天治療失敗或無法忍受其副作用，不得替換使用本藥品；且若使用本藥品治療失敗或無法忍受其副作用，亦不得替換使用</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以上／天治療。</span><span lang="EN-US" style="mso-font-kerning: 0pt"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="text-indent: -20pt; margin-left: 50pt; margin-right: 2.4pt; margin-top: 0cm; margin-bottom: .0001pt"><font size="2"><u><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">３、<span style="letter-spacing:-.05pt">需經事前審查核准後使用。（</span></span><span lang="EN-US" style="letter-spacing:-.05pt">98/5/1</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;;letter-spacing:-.05pt">）</span></u><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                                <td width="304" valign="top" style="width:227.9pt;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0cm 1.4pt 0cm 1.4pt;height:5.65pt">
                                  <p class="044-1" style="margin-top:0cm;margin-right:2.4pt;margin-bottom:0cm;
  margin-left:24.5pt;margin-bottom:.0001pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US" style="mso-bidi-font-weight:bold">9.31. 
                                  　Sunitinib</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;;mso-bidi-font-weight:bold">（如</span><span lang="EN-US" style="mso-bidi-font-weight:bold">Sutent</span><span style="font-family:新細明體;
  mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;;
  mso-bidi-font-weight:bold">）</span><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">：（</span><span lang="EN-US">98/2/1</span><span style="font-family:新細明體;mso-ascii-font-family:
  &quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）</span><span lang="EN-US"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="text-indent: -20pt; margin-left: 50pt; margin-right: 2.4pt; margin-top: 0cm; margin-bottom: .0001pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">１、</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">限用於以</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以下（含）／天治療期間出現疾病惡化或對該藥出現不能忍受之腸胃道間質腫瘤。</span><span lang="EN-US" style="mso-font-kerning: 0pt"><o:p>
                                  </o:p>
                                  </span></font></p>
                                  <p class="044-1" style="text-indent: -20pt; margin-left: 50pt; margin-right: 2.4pt; margin-top: 0cm; margin-bottom: .0001pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
  &quot;Times New Roman&quot;">２、</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">若使用</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以上／天治療失敗或無法忍受其副作用，不得替換使用本藥品；且若使用本藥品治療失敗或無法忍受其副作用，亦不得替換使用</span><span lang="EN-US" style="mso-font-kerning: 0pt">imatinib 
                                  mesylate 400mg</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-font-kerning: 0pt">以上／天治療。</span><span lang="EN-US" style="mso-bidi-font-size:14.0pt"><o:p>
                                  </o:p>
                                  </span></font></p>
                                </td>
                              </tr>
                            </table>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">備註：劃線部份為新修訂之規定。</font></span></p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30570]]></MetaId>
<Doc_Style_LName><![CDATA[行政規則]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[行政程序法第159條第2項第2款]]></Doc_Style_SName>
<Chapter><![CDATA[衛生勞動篇]]></Chapter>
<PubGov><![CDATA[勞委會]]></PubGov>
<PubGovName><![CDATA[勞工保險監理委員會]]></PubGovName>
<UndertakeGov><![CDATA[勞工保險監理委員會]]></UndertakeGov>
<Officer_name><![CDATA[主任委員 郭吉仁]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[保監業字第0980060217號]]></GazetteId>
<Title><![CDATA[勞工保險監理委員會令：本會59年6月25日勞監業字第1025號函釋，自即日廢止]]></Title>
<TitleEnglish><![CDATA[LABOR INSURANCE SUPERVISORY COMMISSION Order is hereby given, for cease-applying the interpretive rules prescribed and documented as Lao-Chien-Yeh-Tzu No.1025 in pursuant to "Labor Insurance Act" which shall be effective from 2nd, April 2009]]></TitleEnglish>
<ThemeSubject><![CDATA[本會發布之中華民國五十九年六月二十五日勞監業字第一 O二五號函釋，自即日廢止。]]></ThemeSubject>
<Keyword><![CDATA[法令廢止;勞工保險(勞保);被保險人;受益人;保險給付(保險金額給付，保險賠款，保險理賠);勞工保險條例(勞保條例)]]></Keyword>
<Eng_Keyword/>
<Explain/>
<Category><![CDATA[890]]></Category>
<Cake><![CDATA[J38;942]]></Cake>
<Service><![CDATA[542]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch08/type2/gov71/num15/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><a href="http://monitor.bli.gov.tw/"><b>勞工保險監理委員會</b></a><b>令</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">保監業字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980060217</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="0131-1" style="margin-left:33.0pt;text-indent:-33.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">本會發布之中華民國五十九年六月二十五日勞監業字第一○二五號函釋，自即日廢止。</font></span></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">主任委員　楊通軒</font></span></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30568]]></MetaId>
<Doc_Style_LName><![CDATA[行政規則]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[行政程序法第159條第2項第2款]]></Doc_Style_SName>
<Chapter><![CDATA[衛生勞動篇]]></Chapter>
<PubGov><![CDATA[勞委會]]></PubGov>
<PubGovName><![CDATA[勞工保險局]]></PubGovName>
<UndertakeGov><![CDATA[勞工保險局]]></UndertakeGov>
<Officer_name><![CDATA[總經理 蔡吉安]]></Officer_name>
<Date_Created><![CDATA[中華民國98年4月2日]]></Date_Created>
<GazetteId><![CDATA[保財欠字第09860020262號]]></GazetteId>
<Title><![CDATA[勞工保險局令：修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第3點規定，自即日生效]]></Title>
<TitleEnglish><![CDATA[BUREAU OF LABOR INSURANCE Order is hereby given, for the revision on Paragraph 3 of "Subsidy Directions on Administration Expense for Professional Unions and Fishermen's Associations Handle Labor Insurance Affairs" (revised directions take into force from 2nd, April 2009)]]></TitleEnglish>
<ThemeSubject><![CDATA[修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第三點，並自即日生效。]]></ThemeSubject>
<Keyword><![CDATA[工會(職業工會);漁會;勞工保險(勞保);政府補助;保險費(保費);核銷;勞工保險局(勞保局)]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第三點，並自即日生效。
    附修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第三點]]></Explain>
<Category><![CDATA[890]]></Category>
<Cake><![CDATA[J38;A34;942]]></Cake>
<Service><![CDATA[542]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch08/type2/gov71/num16/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><a href="http://www.bli.gov.tw/"><b>勞工保險局</b></a><b>令</b></span></font>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">保財欠字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">09860020262</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="0131-1" style="margin-left:33.0pt;text-indent:-33.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第三點，並自即日生效。</font></span></p>
                            <p class="0132-2" style="margin-left:33.15pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">附修正「職業工會漁會辦理勞工保險業務行政事務費補助要點」第三點</font></span></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">總</span> <span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">經</span> 
                            <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">理　蔡吉安</span></font></p>
                            <p class="021">　</p>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2"><b>職業工會漁會辦理勞工保險業務行政事務費補助要點第三點修正</b></font></span><font size="2"><b><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">規定</span></b></font></p>
                            <p class="0221" align="right" style="margin-left:20.1pt;text-align:right;
text-indent:-20.1pt"><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">勞工保險局</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">4</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">2</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日保財欠字第</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">09860020262</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">號令發布</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0221" style="margin-left:22.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、職業工會及漁會申請補助行政事務費之程序如下：</font></span></p>
                            <p class="0222" style="text-indent: -18pt; margin-left: 30pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">職業工會及漁會行政事務費補助每年申請一次，申請時應填具「勞工保險局補助職業工會、漁會辦理勞保業務行政事務費申請書」（以下簡稱申請書），並於年度結束前向勞保局申請，該申請書作為核撥依據，逾期申請者不予補助。</span></font></p>
                            <p class="0222" style="text-indent: -18pt; margin-left: 30pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">申請書得併同會員（代表）大會會議紀錄於年度開始前送勞保局，視同年度開始即提出申請。</span></font></p>
                            <p class="0221" style="text-indent: 20pt; mso-char-indent-count: 2.0; mso-char-indent-size: 11.0pt; margin-left: 20pt"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">勞保局於受理申請後，對符合第二點規定者，依下列方式核撥行政事務費：</font></span></p>
                            <p class="0222" style="margin-left:33.5pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">已繳保費月份，應於收到申請書六十日內核撥。</span></font></p>
                            <p class="0222" style="margin-left:33.5pt;text-indent:-22.1pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">應繳保費尚未到期月份，應於繳費後勞保費寬限期滿之翌日起六十日內核撥。</span></font></p>
                            <p class="0221" style="text-indent: 20pt; mso-char-indent-count: 2.0; mso-char-indent-size: 11.0pt; margin-left: 20pt"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">勞保局應按月列印合格清冊，依核定金額直接撥入其帳戶，並以劃撥轉帳之簽收或證明文件作為原始憑證之核銷單據。</font></span></p>
                            <p class="0221" style="text-indent: 20pt; mso-char-indent-count: 2.0; mso-char-indent-size: 11.0pt; margin-left: 20pt"><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">申請書資料不全或不符第二點規定者，勞保局應通知申請人於十日內補正，屆期不補正者，敘明理由，予以退件。</font></span></p>
                            <p class="013" style="margin-left:33.0pt;text-indent:-33.0pt">　</p>
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
<Record>
<MetaId><![CDATA[30567]]></MetaId>
<Doc_Style_LName><![CDATA[公告及送達]]></Doc_Style_LName>
<Doc_Style_SName><![CDATA[法規命令訂定、修正草案及廢止案之預告]]></Doc_Style_SName>
<Chapter><![CDATA[衛生勞動篇]]></Chapter>
<PubGov><![CDATA[衛生署]]></PubGov>
<PubGovName><![CDATA[行政院衛生署]]></PubGovName>
<UndertakeGov><![CDATA[行政院衛生署]]></UndertakeGov>
<Officer_name><![CDATA[署長 葉金川]]></Officer_name>
<Date_Created><![CDATA[中華民國98年3月30日]]></Date_Created>
<GazetteId><![CDATA[衛署藥字第0980305264號]]></GazetteId>
<Title><![CDATA[行政院衛生署公告：預告適用「罕見疾病防治及藥物法」之藥物品項修正草案]]></Title>
<TitleEnglish><![CDATA[DEPARTMENT OF HEALTH, EXECUTIVE YUAN Notice is hereby given, to commence a period of public comment for the draft amendment of "List of Orphan Drug Designations and Approvals", which complies with the provisions of the "Rare Disease and Orphan Drug Act"]]></TitleEnglish>
<ThemeSubject><![CDATA[預告修正適用「罕見疾病防治及藥物法」之藥物品項。]]></ThemeSubject>
<Keyword><![CDATA[罕見疾病防治及藥物法;罕見疾病;藥物(藥品);許可證]]></Keyword>
<Eng_Keyword/>
<Explain><![CDATA[一、修正機關：行政院衛生署
二、修正依據：罕見疾病防治及藥物法第三條第二項及第二十三條。
三、修正內容：
    (一)新增「Ambrisentan, 5 and 10 mg tablet」用於「原發性肺高血壓」、「Natalizumab, 300 mg/15 ml vial, solution for infusion」用於「多發性硬化症」及「Sildenafil citrate, 20 mg tablet」用於「原發性肺高血壓」等3項藥品為適用「罕見疾病防治及藥物法」之藥物（附件名單中第9、44及58項）。
    (二)修正適用「罕見疾病防治及藥物法」之藥物劑型、劑量及適應症：
        (１)修正「Artemisinin」適應症為「瘧疾」（附件名單中第14項）；
        (２)新增「Iloprost, solution for infusion」劑型（附件名單中第31項）；
        (３)修正「Iodoquinol」適應症為「阿米巴性痢疾」（附件名單中第35項）；
        (４)新增「Ivermectin, 3 mg tablet」劑量（附件名單中第36項）；
        (５)新增「Niemann-Pick Disease Type C」為罕見疾病藥物「Miglustat」適應症（附件名單中第41項）；
        (６)修正「Paromomycin sulfate」適應症為「隱孢子蟲感染、阿米巴性痢疾」（附件名單中第47項）；
        (７)修正「Primaquine-phosphate」劑量為「7.5 mg tablet」，適應症為「瘧疾、肺囊蟲肺炎」（附件名單中第51項）；
        (８)修正「Pyrimethamine-sulfadiazine」成分為「Pyrimethamine」，劑量為「25 mg tablet」（附件名單中第53項）；
        (９)修正「Pyrimethamine-sulfadoxine-mefloquine」成分為 「mefloquine」，劑量為「250 mg tablet」，適應症為「瘧疾」（附件名單中第54項）；
        (１０)修正「taltirelin hydrate」適應症為「Spinocerebellar ataxia脊髓小腦退化性動作協調障礙」（附件名單中第63項）；
        (１１)新增「Tetrahydrobiopterin（BH4）, 100 mg tablet」劑量，並修正適應症為「Treatment of patients with hyperphenylalaninemia due to tetrahydrobiopterin deficiency. Tetrahydrobiopterin-responsive phenylketonuria(PKU).」（附件名單中第65項）。
    (三)刪除「Benznidazole」、「Eflornithine HCL」、「Meglumine Antimoniate」、「Melarsoprol」、「Metrifonate」、「Nifurtimox」、「Oxamniquine」、「Proguanil」、 「Pyrimethamine + Sulfadoxine」及「Suramin」等10項藥品為適用「罕見疾病防治及藥物法」之藥物。
    (四)本案另載於本署全球資訊網站http：//www.doh.gov.tw，衛生署公告網頁。
四、對於本公告內容如有任何意見或修正建議者，請於本公告刊登公報次日起10日內陳述意見或洽詢：
    (一)承辦單位：行政院衛生署藥政處
    (二)地址：台北市林森北路80號10樓
    (三)電話：（02）85906885
   (四)傳真：（02）25237318
   (五)電子郵件：pafanyin@doh.gov.tw]]></Explain>
<Category><![CDATA[840]]></Category>
<Cake><![CDATA[J33;B21]]></Cake>
<Service><![CDATA[B61]]></Service>
<GazetteHTML><![CDATA[http://gazette.nat.gov.tw/EG_FileManager/eguploadpub/eg015061/ch08/type3/gov70/num17/Eg.htm]]></GazetteHTML>
<HTMLContent><![CDATA[<!--inner content block starts -->
				<!-- InstanceBeginEditable name="innerContent" -->

				<div class="">
				<!--  public page content block starts  -->
				<table style="width:775px" border="0" cellspacing="20" cellpadding="0" summary="本期公報內容表格">
					<tr>
						<td style="width:20%">
                            <span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA"><font size="2"><b><a href="http://www.doh.gov.tw/cht2006/index_populace.aspx">行政院衛生署</a>公告</b></font></span>
						</td>
						<td style="width:601 px">
                            <font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-font-kerning: 1.0pt; mso-ansi-language: EN-US; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA; layout-grid-mode: line">日<br>
                            </span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">衛署藥字第</span><span style="mso-bidi-font-size: 18.0pt; font-family: Times New Roman; mso-fareast-font-family: 新細明體; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">0980305264</span><span style="mso-bidi-font-size: 18.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman; mso-bidi-font-family: Times New Roman; mso-ansi-language: ZH-TW; mso-fareast-language: ZH-TW; mso-bidi-language: AR-SA">號</span></font>
						</td>
					</tr>
					<tr>
						<td colspan="2" style="width:733px">
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">主　　旨：預告修正適用「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1L0030003">罕見疾病防治及藥物法</a>」之藥物品項。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">依　　據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1A0030055">行政程序法</a>第一百五十一條第二項準用第一百五十四條第一項。</font></span></p>
                            <p class="011" style="margin-left:55.0pt;text-indent:-55.0pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">公告事項：</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">一、修正機關：行政院衛生署。</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">二、修正依據：<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1L0030003">罕見疾病防治及藥物法</a>第三條第二項及第二十三條。</font></span></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">三、修正內容：</font></span></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;     
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新增「</span><span lang="EN-US">Ambrisentan, 5     
                            and 10 mg tablet</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」用於「原發性肺高血壓」、「</span><span lang="EN-US">Natalizumab,     
                            300 mg/15 ml vial, solution for infusion</span><span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">」用於「多發性硬化症」及「</span><span lang="EN-US">Sildenafil     
                            citrate, 20 mg tablet</span><span style="font-family:    
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">」用於「原發性肺高血壓」等</span><span lang="EN-US">3</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">項藥品為適用「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1L0030003">罕見疾病防治及藥物法</a>」之藥物（附件名單中第</span><span lang="EN-US">9</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">、</span><span lang="EN-US">44</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">及</span><span lang="EN-US">58</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">項）。</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;     
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正適用「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1L0030003">罕見疾病防治及藥物法</a>」之藥物劑型、劑量及適應症：</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">１</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Artemisinin</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」適應症為「瘧疾」（附件名單中第</span><span lang="EN-US">14</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">２</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新增「</span><span lang="EN-US">Iloprost,     
                            solution for infusion</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」劑型（附件名單中第</span><span lang="EN-US">31</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">３</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Iodoquinol</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」適應症為「阿米巴性痢疾」（附件名單中第</span><span lang="EN-US">35</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">４</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新增「</span><span lang="EN-US">Ivermectin, 3 mg     
                            tablet</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」劑量（附件名單中第</span><span lang="EN-US">36</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">５</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新增「</span><span lang="EN-US">Niemann-Pick     
                            Disease Type C</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」為罕見疾病藥物「</span><span lang="EN-US">Miglustat</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」適應症（附件名單中第</span><span lang="EN-US">41</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">６</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Paromomycin     
                            sulfate</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」適應症為「隱孢子蟲感染、阿米巴性痢疾」（附件名單中第</span><span lang="EN-US">47</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">７</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Primaquine-phosphate</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」劑量為「</span><span lang="EN-US">7.5 mg     
                            tablet</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」，適應症為「瘧疾、肺囊蟲肺炎」（附件名單中第</span><span lang="EN-US">51</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">８</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Pyrimethamine-sulfadiazine</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」成分為「</span><span lang="EN-US">Pyrimethamine</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」，劑量為「</span><span lang="EN-US">25 mg     
                            tablet</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」（附件名單中第</span><span lang="EN-US">53</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -18pt; margin-left: 72pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">９</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">Pyrimethamine-sulfadoxine-mefloquine</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」成分為「</span><span lang="EN-US">mefloquine</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」，劑量為「</span><span lang="EN-US">250 mg     
                            tablet</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」，適應症為「瘧疾」（附件名單中第</span><span lang="EN-US">54</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -28pt; mso-char-indent-count: -3.01; mso-char-indent-size: 10.95pt; margin-left: 82pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">１０</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">修正「</span><span lang="EN-US">taltirelin     
                            hydrate</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」適應症為「</span><span lang="EN-US">Spinocerebellar     
                            ataxia</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">脊髓小腦退化性動作協調障礙」（附件名單中第</span><span lang="EN-US">63</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">項）；</span></font></p>
                            <p class="0123" style="text-indent: -28pt; mso-char-indent-count: -3.01; mso-char-indent-size: 10.95pt; margin-left: 82pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">１１</span><span lang="EN-US">)<span style="mso-tab-count:1"> 
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">新增「</span><span lang="EN-US">Tetrahydrobiopterin</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">（</span><span lang="EN-US">BH4</span><span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">）</span><span lang="EN-US">,     
                            100 mg tablet</span><span style="font-family:新細明體;mso-ascii-font-family:    
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">」劑量，並修正適應症為「</span><span lang="EN-US">Treatment     
                            of patients with hyperphenylalaninemia due to     
                            tetrahydrobiopterin deficiency. Tetrahydrobiopterin-responsive     
                            phenylketonuria(PKU).</span><span style="font-family:新細明體;mso-ascii-font-family:
&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">」（附件名單中第</span><span lang="EN-US">65</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;">項）。</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;     
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">刪除「</span><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">Benznidazole<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Eflornithine HCL<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」、「</span>Meglumine Antimoniate<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」、「</span>Melarsoprol<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Metrifonate<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Nifurtimox<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Oxamniquine<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Proguanil<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」、「</span>Pyrimethamine + Sulfadoxine<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">」及「</span>Suramin<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">」等</span>10<span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">項藥品為適用「<a href="http://law.moj.gov.tw/Scripts/Newsdetail.asp?NO=1L0030003">罕見疾病防治及藥物法</a>」之藥物。</span></span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">(<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四</span>)&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">本案另</span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">載於本署全球資訊網站</span><span lang="EN-US"><a href="http://www.doh.gov.tw">http://www.doh.gov.tw</a></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">，衛生署公告網頁。</span></font></p>
                            <p class="0121" style="margin-left:55.1pt;text-indent:-22.1pt"><font size="2"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四、對於本公告內容如有任何意見或修正建議者，請於本公告刊登公報次日起</span><span lang="EN-US">10</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">日內陳述意見或洽詢：</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span lang="EN-US">(</span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">一</span><span lang="EN-US">)<span style="mso-tab-count:1">&nbsp;     
                            </span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">承辦單位：行政院衛生署藥政處</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">(<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">二</span>)&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">地址：台北市林森北路</span>80<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">號</span>10<span style="font-family:
新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:&quot;Times New Roman&quot;">樓</span></span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">(<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">三</span>)&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">電話：</span>(02)85906885</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">(<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">四</span>)&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">傳真：</span>(02)25237318</span></font></p>
                            <p class="0122" style="text-indent: -18pt; margin-left: 60pt"><font size="2"><span style="font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">(<span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">五</span>)&nbsp; <span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:    
&quot;Times New Roman&quot;">電子郵</span></span><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;">件：</span><a href="mailto:pafanyin@doh.gov.tw"><span lang="EN-US">pafanyin@doh.gov.tw</span></a></font></p>
                            <p class="015" style="margin-top:6.0pt;margin-right:0cm;margin-bottom:6.0pt;
margin-left:0cm"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">署　　長　葉金川</font></span></p>
                            <p>　
                            <p><b><font size="2">適用罕見疾病防治及藥物法之藥物品項修正草案</font></b>
                            <p class="021"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;
mso-hansi-font-family:&quot;Times New Roman&quot;"><font size="2">罕見疾病藥物名單及其適應症</font></span></p>
                            <p class="0221" align="right" style="text-align: right; text-indent: -20.1pt; line-height: 100%; margin-left: 20.1pt; margin-top: 0; margin-bottom: 1"><font size="2"><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">中華民國</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">98</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">年</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">3</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">月</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">30</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">日衛署藥字第</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt">0980305264</span><span style="mso-bidi-font-size: 12.0pt; font-family: 新細明體; mso-ascii-font-family: Times New Roman; mso-hansi-font-family: Times New Roman">號公告</span><span lang="EN-US" style="mso-bidi-font-size: 12.0pt"><o:p>
                            </o:p>
                            </span></font></p>
                            <p class="0221" style="text-indent: -22.1pt; line-height: 100%; margin-left: 22.1pt; margin-top: 1; margin-bottom: 1"><span style="font-family:新細明體;mso-ascii-font-family:&quot;Times New Roman&quot;;mso-hansi-font-family:
&quot;Times New Roman&quot;"><font size="2">認定日期：公告列入罕見疾病藥物名單中；許可日期：核發許可證，准予上市日期</font></span></p>
                            <p style="text-indent: 0; margin-left: 0; margin-top: 0"><font size="2"><img border="0" src="images/images001.gif" width="740" height="436"><img border="0" src="images/images002.gif" width="740" height="505"><img border="0" src="images/images003.gif" width="740" height="504"><img border="0" src="images/images004.gif" width="740" height="504"><img border="0" src="images/images005.gif" width="740" height="505"><img border="0" src="images/images006.gif" width="740" height="504"><img border="0" src="images/images007.gif" width="740" height="506"><img border="0" src="images/images008.gif" width="740" height="505"><img border="0" src="images/images009.gif" width="740" height="504"><img border="0" src="images/images010.gif" width="740" height="503"><img border="0" src="images/images011.gif" width="740" height="88">
                            </font>
                            <p>　
                            <p>　
						</td>
					</tr>
				</table>
				<!--  public page content block starts  -->
				</div>

				<div class="top"><a href="#">Top</a></div>

                <!-- InstanceEndEditable -->
                <!-- inner content block ends -->]]></HTMLContent>
</Record>
</Gazette>
